Skip Navigation

Projects

  1. 2/2 Schizophrenia Heterogeneity and Toxoplasma Exposure
  2. AIDS Clinical Trials Group Network ("ACTG") - Community Health Promoter Program
  3. Ambient Air Pollution And Respiratory Outcomes In Children
  4. Application for CFF Accreditation and Funding 2010/2011
  5. Assessing Cost Effectiveness of Zevalin in the Management of Non Hodgkin Lymphoma
  6. Assessment of the Effectiveness of Rotarix Vaccine Under Routine Use In Georgia
  7. Augmenting Cystic Fibrosis Management Using Smart Devices with Web 2.0 Application
  8. Breast and Prostate Cancer Data Quality and Patterns of Care (PoC-BP) Study
  9. Broad Based Research Collaborative on Minority Health
  10. caBIG Imaging Workspace SME (061510 start)
  11. caBIG Architecture Workspace (091610 start)
  12. caGrid Core Focus Development 1.x
  13. The Cagrid Knowledge Center
  14. CardioVascular Research Grid (CVRG) Renewal (sub to JHU)
  15. Caregiver Stress: Interventions to Promote Health & Well-Being
  16. CDC Intergovernmental Personnel Agreement (IPA)
  17. CDC IPA-Dr. Kimberly Rask
  18. CDC IPA for Stephen Pitts
  19. CER Hub Kaiser Permanente NLP
  20. China-U.S. Health Reform Conference
  21. Clinical and Policy Implications of a Statewide Emergency Telepsychiatry Program
  22. Cognitive Complexity and Error in Critical Care
  23. COHORTS Sub-Contractual Agreements for Emory - Guatemala Site
  24. Colorectal Chemoprevention with Calcium and Vitamin D
  25. Community Vulnerability and Responses to Idu-Related Hiv
  26. Development of eHealth Smoking Intervention for Community Colleges
  27. Diabetes Care in Nursing Home Residents
  28. Effectiveness of Screening Colonoscopy in Reducing Deaths from Colorectal Cancer
  29. Electronic Patient Tracking and Emergency Department Information System (EDIS)
  30. An Electronic Personal Health Record for Mental Health C
  31. Eliminating Disparaties for Patients with Lymphoma
  32. Enhancing Adolescent Immunization through Parent and Teacher Interventions
  33. Enhancing the Effectiveness of a Culturally Sensitive OR
  34. Evaluating Kaiser Permanente Northern California's Employee Wellness Program
  35. An Evaluation of Vaccination Practices of Nursing Home Resident and Staff
  36. Examine the Relationship Between Health Risks And Costs and Program Return
  37. Family Health Initiative (FHI) in Bihar, India
  38. GA BASICS (Brief Assessment, Screening, intervention Continuum of Care System)
  39. GA Department of Community Health Tuberculosis Medical Consultation
  40. Georgia Cancer Coalition & Distinguished Cancer Clinical
  41. Georgia DCH and Emory for Cystic Fibrosis Medical Care for Children
  42. Global Tobacco Technical Assistance Consortium
  43. Building a Grid-Enabled Registry Resource for Comprehensive Cancer Research in GA
  44. Group Interventions for Abused, Suicidal Black Women
  45. A Health Policy Network Stimulating Innovation and Policy Options
  46. Health Reform in Europe
  47. Hybrid Revascularization Vs Percutaneous Coronary Intervention: A Planning Grant
  48. Image Mining for Comparative Analysis of Expression Patterns in Tissue Microarray
  49. Implementation of an Evidence-Based PTSD Treatment in Public Sector Mental Health
  50. Improving Primary Care of Patients with Mental Disorders
  51. In-Depth Analysis Of Qualitative Texts from Intensive Meditation Retreat Experience
  52. Project Name
  53. Ipa for Dr. Joseph Lipscomb-Cancors
  54. IPA for Sandra Helmers with CDC
  55. Kabi-Pharmacia International Growth Study (KIGS)
  56. Kaiser Permanente Subcontract With Emory University for
  57. The Kenya Health Work Force Project
  58. Kidney Function with Vitamin D/Calcium (KFS)
  59. Limited Competition: Clinical Centers for the Halt-Poly
  60. Limited Competition For The Continuation Of The Consortium For Radiologic Imaging Studies
  61. Longitudinal Validation Of Promise Pediatrics Item Banks
  62. Maine's Savvy Caregiver Project -Enhancement
  63. Management Practices and the Risk of Infections following Cardiac Surgery
  64. Measuring the Benefits of Sanitation, Water Quality, and Handwashing Interventions
  65. Medical Assistance Program
  66. Mental Health Concentration Lecture Series
  67. Mind Body Interactions In Cardiovascular Disease
  68. Minority Health-Grid Network: A Genomics Resource for Health Disparity Research
  69. Modeling Officer - Level Effects of Crisis Intervention
  70. Neurobiology of Mild Cognitive Impairment in the Elderly
  71. NICHD Neonatal Research Network Capitation Funding
  72. Nutrition and Health Sciences
  73. Opening Doors to Recovery in Southeast Georgia
  74. Evaluation of the Planning for Healthy Babies (P4HB) Family Planning Waiver Progra,
  75. Patient and Provider Influences on Disparities in Colorectal Cancer Care
  76. A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
  77. Physician Workflow and Scheduling Improvements Can Lead to Increased Efficiency
  78. Policy Analysis of the Equity in the Financing of Medicaid
  79. Positively Transforming Emory's Diverse Culture: Reducing Stigma and Promoting Caring
  80. Predictive Biology: Adaptability, Robustness and the fundamental Laws of Biology
  81. Pregnancy Health Among Florida Farmworkers
  82. Prevalence and Correlates of Human Papillomavirus (HPV) Vaccination in Rural Areas
  83. Prevent and Reduce Adverse Health Effects Of Pesticides
  84. Preventive Psychological Health Demonstration Projects
  85. Proposal for the BCBSA Healthcare Delivery Initiatives Measurement Project
  86. Proposal to Provide Consulting Support for Development of an Epidemiological
  87. Psychosocial Effects on Patient Adherence Allostatic LOA
  88. Public Housing Relocations: Impact on HIV Risk and Drug Use
  89. Raising Literacy and Capacity for Incontinence and Skin
  90. Sickle Cell Pain: A Novel Approach to Assessment and Relief
  91. SNAP Participation, Food Choices, Nutritional & Health Outcomes among Low Income
  92. Social and Behavioral Interventions to Increase Organ and Tissue Donation
  93. Society of Hospital Medicine GCMI-2
  94. Thomas Reuters Sub-Conract-Care Continuum56
  95. Thomson Reuters Value Based Benefit Design Study (BMS-VBBD)
  96. Titan One Touch Release
  97. Training Program in Academic Pulmonary Medicine
  98. Translational Research For The Prevention and Control of Diabetes and Obesity
  99. Using Cancer Registry and Other Data Sources to Track Measures of Care in Georgia
  100. 2/2 Schizophrenia Heterogeneity and Toxoplasma Exposure
  101. A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
  102. ACTG Minority HIV Investigator Mentorship Awards
  103. Application for CFF Accreditation and Funding 2010/2011
  104. Assessing Cost Effectiveness of Zevalin in the Management of Non Hodgkin Lymphoma
  105. Assessment of the Effectiveness of Rotarix Vaccine Under Routine Use In Georgia
  106. Broad Based Research Collaborative on Minority Health
  107. Build and License StayWell ROI Model
  108. caGrid Core Focus Development 1.x
  109. CardioVascular Research Grid (CVRG) Renewal (sub to JHU)
  110. Caregiver Stress: Interventions To Promote Health & Well-Being
  111. CDC IPA-Dr. Kathleen Adams
  112. CDC IPA-Dr. Kimberly Rask
  113. Center for AIDS Research at Emory University
  114. CER Hub Kaiser Permanente NLP
  115. Chemotheraphy Adherence Decision Making in Early Stage Brest Cancer
  116. Clinical and Policy Implications of a Statewide Emergency Telephychiatry Program
  117. Clinical Resource for Lung and Alcohol Investigations
  118. Cognitive Complexity and Error in Critical Care 2012
  119. COHORTS Sub-Contractual Agreements for Emory - Guatemala Site
  120. Colorectal Chemoprevention with Calcium and Vitamin D
  121. Community Vulnerability And Responses To Idu-Related HIV
  122. Compassion Meditation for Suicidal African American Women
  123. Comprehensive Evaluation Support for the Federal Employee Worksite Health and Wellness Initiative
  124. Cost Effectiveness and Quality Of Life in Heart Failure (Patients With Diabetes)
  125. Delivering a Dose of Hope: A Faith-Based Program to Increase Older African American
  126. Development of a Health and Human Performance Index (HaHPI)
  127. Development of eHealth Smoking Intervention for Community Colleges
  128. Effectiveness of Screening Colonoscopy in Reducing Deaths from Colorectal Cancer
  129. Effects of Health Literacy on HIV Clinical Outcomes
  130. Enhancing Adolescent Immunization through Parent and Teacher Interventions
  131. Evaluating the Health and Wellness of Prudential Financial's Telecommuter Population
  132. Exploring HIV/AIDS Ambulatory Healthcare Use by Black Women in the South
  133. Family Health Initiative (FHI) in Bihar, India
  134. GA Department of Community Health Tuberculosis Medical Consultation
  135. Georgia DCH and Emory for Cystic Fibrosis Medical Care for Children
  136. Global Tobacco Technical Assistance Consortium
  137. A Health Policy Network Stimulating Innovation and Policy Options
  138. Health Reform in Europe
  139. Identifying the Elements of an Optimal Healing Environment and Integrative Practice
  140. Implementation of an Evidence-Based PTSD Treatment in Public Sector Mental Health
  141. Improving Primary Care of Patients with Mental Disorders
  142. IPA For David H. Howard
  143. IPA For Flour Fortification Initiative
  144. IPA for Sandra Helmers with CDC
  145. IPA-VA-South Carolina
  146. The Kenya Health Work Force Project
  147. Knowledge, Attitudes and Beliefs about Sickle Cell Disease (SCD) in Kumasi, Ghana
  148. Large-Scale Analytics on Exascale Systems with Deep Memory Hierarchies - ORNL
  149. Limited Competition: Clinical Centers For The Halt-Poly
  150. Longitudinal Validation Of Promise Pediatrics Item Banks
  151. Maine's Savvy Caregiver Project -Enhancement
  152. Measuring the Benefits of Sanitation, Water Quality, and Handwashing Interventions
  153. Medical Assistance Program 2012
  154. Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
  155. Mind Body Interactions In Cardiovascular Disease
  156. Minority Health-Grid Network: A Genomics Resource for Health Disparity Research
  157. Neurobiology of Mild Cognitive Impairment in the Elderly
  158. Neurological Emergencies Treatment Trials (NETT) Network Clinical Site Hubs
  159. NICHD Neonatal Research Network Capitation Funding
  160. Operation of Statewide GA Comprehensive Cancer Registry
  161. Patient and Provider Influences on Disparities in Colorectal Cancer Care
  162. Predicting Patient Subpopulation Dynamics from Fluctuation Theory
  163. Pregnancy Health Among Florida Farmworkers
  164. Prevent and Reduce Adverse Health Effects of Pesticides
  165. Preventive Psychological Health Demonstration Projects
  166. Project ACTS II: Increasing Donor Registration among African Americans
  167. Proposal to Examine the Relationship Between Tobacco Use and Costs at Whirlpool
  168. Promoting Public Health Priorities Through Policy Analysis
  169. Proposal to Provide Consulting Support for Development of an Epidemiological
  170. Public Housing Relocations: Impact On HIV Risk And Drug Use
  171. Rapid Development and Deployments of Non-Physician Providers In Critical Care
  172. Reversing Type 1 Diabetes After it is Established
  173. RTI Proposal: Understanding the Role of Healthcare Facility Design
  174. Sickle Cell Pain: A Novel Approach to Assessment and Relief
  175. Social and Behavioral Interventions to Increase Organ and Tissue Donation
  176. Surveillance, Epidemiology and End Results (SEER)
  177. Sustaining Investment In IANPHI: Supplement To Existing Grant
  178. Tailoring an Intervention with Parents in Rural Areas to Reduce HPV Transmission
  179. Thomson Reuters Value Based Benefit Design Study (BMS-VBBD)
  180. Thomson Reuters Sub-Contract Care Continuum Phase 1
  181. Training in Interventions to Improve Outcomes in Chronic Conditions
  182. Understanding Factors Contributing to Women's HIV Risk in the United States
  183. The VA Diabetes Review Merit
  184. Virtual Reality Technology as a Treatment for Overweight Children with NAFLD
  185. William H. Foege Global Health Fellows Workshop
  186. 2/2 Schizophrenia Heterogeneity and Toxoplasma Exposure
  187. A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
  188. Accountable Care Units: A Model for Nurse-Led Acute Care Collaborative Practice
  189. African Health Workforce Project
  190. Alliance for Reducing Cancer Northwest SIP 09-002
  191. Ambient Air Pollution And Respiratory Outcomes In Children
  192. An Integrated Assessment of Emissions, Air Quality, Economic, and Health Impacts
  193. Analytic and Consulting Support for the Good Health Index Project
  194. Analytic Methods for Determining Multimodal Biomarkers for Parkinson's Disease
  195. Antecedents and Outcomes Of Self-Care In Adults with Congenital Heart Disease
  196. Appalachian Integrated Care and Wellness
  197. Assessing Impact of MI Fortification of Staples- Iron Status & Anemia- Costa Rica
  198. Atlanta VA TeleDermatology Service Program (IPA: Bradley; Sponsor: S. Chen)
  199. Automated Web-Based Behavioral Diagnostics of Cognitive Impairment
  200. Biological Variants Underlying Racial Differences in Lymphoma
  201. Brief Interventions to Create Smoke-Free Home Policies in Low-Income Households
  202. Building Capacity to Control Viral Foodborne Disease: A Translational, Multidisciplinary Approach
  203. C-Path ADPKD Clinical Database Project
  204. Cardiovascular Research Grid (CVRG) Renewal (sub to JHU)
  205. CARES Program
  206. CDC IPA-Dr. Zhou Yang
  207. CDC Intergovernmental Personnel Agreement (IPA)
  208. CDC IPA David Kleinbaum
  209. CDC IPA-Dr. David Howard
  210. CDC IPA-Dr. Kathleen Adams
  211. CDC IPA-Dr. Kimberly Rask
  212. Sasser CDC IPA
  213. CDC-IPA-Dr. Steven Culler
  214. CDC IPA Taussig
  215. CDC-IPA W. Dana Flanders
  216. CDC: To Kill a Kelpie
  217. Center for AIDS Research at Emory University
  218. Center for Aids Research (Pilot) Incidence of Non-Aids A
  219. The Center for Cognition and Affect in Chronic Illness
  220. The CFAR Social & Behavioral Science Research Network National Scientific Meeting
  221. The Childhood Liver Disease Research and Education Network (ChilDREN)
  222. Children's Center for Clinical and Translational Research
  223. Clinical Outcomes Monitoring of Belatacept-Treated Kidney Transplant Recipients: a
  224. Cognitive Complexity and Error in Critical Care
  225. Community Vulnerability And Responses To Idu-Related HIV
  226. Comprehensive HIV Prevention Package for MSM in Southern Africa
  227. Connect Registry
  228. Consulting to SESI on a National Integrated Health Management Strategy.
  229. Consulting to Support the Development of Enterprise-Wide Health Metrics at Chevron
  230. Center for Clinical Outcomes Research and Public Health (CORPH)
  231. Corporate Health Promotion Programs, Exploring New Ways to Engage Business Leaders
  232. CRC Program Evaluation
  233. DBHDD Contract-Emory Univ School of Medicine-Deaf Svcs
  234. DCFI Young & Strong: An Education & Supportive Care Intervention Study
  235. Delivering a Dose of Hope: A Faith-Based Program to Increase Older African American
  236. Developing Checklists for Flu 2013
  237. Development of Competencies for Heart Disease and Stroke Prevention
  238. Development of eHealth Smoking Intervention for Community Colleges
  239. Diabetes Prevention for Mothers with Gestational Diabetes
  240. eCoach: Development and Pilot Testing of Decision Aid for Prostate Cancer
  241. Effect of Nutrition, Immunity, and Vaccines on Pediatric
  242. Effects of Habitat Disturbance on the Behavioral Ecology, Stress Levels
  243. Effects of Health Literacy on HIV Clinical Outcomes
  244. Emory Aids International Training And Research Program
  245. Emory Breastfeeding Education Project
  246. Emory Center for Injury Control
  247. Enhancing Adolescent Immunization through Parent and Teacher Interventions
  248. Enhancing Patient Education And Communication for Cardiac Catheterization
  249. Enhancing Promise in Pediatric Pain
  250. Evaluating Prediction Models for Cancer Endpoints Subject to Dependent Censoring
  251. Evaluation of the Zero Tolerance Policy at Emory University Hospital Midtown: Elec
  252. Faith Based HIV Prevention for Women
  253. Feasibility of an Internet-Based Model for Implementation of a Prevention Program
  254. Fellowship in Family Planning
  255. Family Health Initiative (FHI) in Bihar, India
  256. Food Security and Community Health During Livelihood Transition In Ethiopia
  257. Functional Magnetic Resonance Imaging (fMRI) of Canine Brain Responses
  258. GA Department of Community Health Tuberculosis Medical Consultation
  259. Gender-Specific Coronary Plaque Characteristics and Risk of Myocardial Infarction
  260. Georgia Department of Public Health
  261. Georgia School Based Health Center Project
  262. Global Tobacco Technical Assistance Consortium
  263. Harland Austin CDC-IPA
  264. A Health Policy Network Stimulating Innovation and Policy Options
  265. Health Reform in Europe
  266. Healthcare Cost Containment Initiative
  267. Healthy Beginnings System of Care Evaluation
  268. HIV-Related Behavior among Rural African American Young Adult Men
  269. HIV Treatment Delays in Latinos: Testing a Model for Social Influence and Trust
  270. Identifying Symptom Clusters In Patients With Head and Neck Cancer Post Combined C
  271. IHME-UoW: Efficacy to Effectiveness Project
  272. Impact of Hospital-Based Chaplain Support on Decision-Making During Serious Illness
  273. Impact of Volume and Temporal Distance on the Value of Organ Transplant Surgery
  274. 3Implementation of an Evidence-Based PTSD Treatment in Public Sector Mental Health
  275. Improving Primary Care of Patients with Mental Disorders
  276. Increasing Reach and Implementation of Evidence Based Programs for Cancer Control
  277. Infantile Spasms: Clinical and Genetic Predictors of Outcomes and Therapeutic Insi
  278. Inflammation, Stress, and Social Behavior: Using Ecological Assessments and Model
  279. Informatics for Integrative Brain Tumor Whole Slide Analysis
  280. An Integrated Approach to Consent-­related Challenges in Acute Cardiology Research
  281. Integrated Care for Co-morbid Depression and Diabetes in India
  282. IPA with CDC for Phyllis Kozarsky
  283. IPA-DMPA And Contraceptive Implants on HIV Transmission in Malawi
  284. IPA For David H. Howard
  285. Ipa for Dr. Joseph Lipscomb-Cancors
  286. IPA - Kenneth Hepburn
  287. IPA Agreement for Qi Long
  288. IPA for Sandra Helmers with CDC
  289. IPA-VA-South Carolina
  290. Kiids: Knowing About Intervention Implementation In Detention Sites
  291. Knowledge Attitudes, and Practices of Providers Regarding
  292. KXL-001-A Multi-Center, Randomized, Placebo-Controlled Evaluation of the
  293. Limited Competition: Clinical Centers for the Halt-Poly
  294. Limited Competition For The Continuation Of The Corsortium For Radiologic Imaging Studies
  295. The Living Well Project: Early Palliative Care and MI for persons with AIDS
  296. Longitudinal Studies of HIV-Associated Lung Infections and Complications
  297. Longitudinal Validation Of Promise Pediatrics Item Banks
  298. Maternal and Child Health Doctoral Training Program
  299. Maternal Obesity, Weight Gain, and The Black-White Disparity In Pregnancy Outcome
  300. Measuring the Benefits of Sanitation, Water Quality, and Handwashing Interventions
  301. Medical Assistance Program 2013
  302. Mental Health Certificate Program Lecture Series Kaiser Permanente Grant
  303. Mental Stress Ischemia: Mechanisms and Prognosis
  304. Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
  305. Mentoring and Research: Public Health Interventions to Improve Health in SMI
  306. Method Development for Survival Dynamic Regression in Chronic Disease Research
  307. Mind Body Interactions In Cardiovascular Disease
  308. Minority Health-Grid Network: A Genomics Resource for Health Disparity Research
  309. A Mobile Personal Health Record for Behavioral Health Homes
  310. Models for Improving Surveillance of Environmentally-Mediated Infectious Diseases
  311. Monitoring and Evaluation of J&J Gateway to a Healthy CommunityTM; Healthier Kids
  312. MSA for Emory University Dept of Neurology and UCB
  313. Multi-Center Assessment of Health Literacy and Oral Health
  314. A Multimedia, Group-Based Clinical Care and Support Model to Increase Dual Protect
  315. National Clinical Strategies for Appropriate Radiation Dose Reduction
  316. Network for Cardiothoracic Surgical Investigations
  317. Newborn Screening, Malnutrition and Lung Disease in Children with Cystic Fibrosis
  318. NICHD Cooperative Multicenter Neonatal Research Network
  319. NICHD Neonatal Research Network Capitation Funding
  320. Norditropin National Registry
  321. Novel Systemic Therapy to Improve Clinical Outcome In Small Cell Lung Cancer
  322. NSF Ecology of Infectious Diseases Grant # 0811934
  323. Osteonecrosis of the Jaw (ONJ) Case Registry
  324. Operation of Statewide GA Comprehensive Cancer Registry
  325. Optimal Timing of Early Intervention to Prevent PTSD
  326. Orissa Trial- Assessing the Effect of Improved Rural Sanitation on Diarrhea
  327. Outcomes of Children with Juvenile Idiopathic Arthritis-Associated Uveitis
  328. Outpatient Clinical Treatment Services for Hansen's Disease
  329. Evaluation of the Planning for Healthy Babies (P4HB) Family Planning Waiver Progra,
  330. Parenting, Alcohol Use and Sexual Risk Among Young African-American Mothers
  331. Patient and Provider Influences on Disparities in Colorectal Cancer Care
  332. Patient-Centered Care: What Factors Drive Outcomes in the Hospital Setting?
  333. Pediatric Environmental Health Specialty Unit (PEHSU)
  334. Physical Activity to Modify Sequelae and Qol In Childhood
  335. Pitts DHHS IPA
  336. Place Characteristics & Disparities in HIV in IDUs: A Multilevel Analysis of NHBS
  337. Policy Intervention for Pediatric Asthma
  338. Practical Two-Step Screening for CFRD And Prediabetes
  339. Predicting Patient Subpopulation Dynamics from Fluctuation Theory
  340. Pregnancy Folate Status & Early Childhood Respiratory & Atopic Disease Outcomes
  341. Project ACTS II: Increasing Donor Registration among African Americans
  342. Proposal to Conduct the HERO Scorecard Validation Study
  343. Prospective Study to Determine the Efficacy and Safety of a Hospital Discharge
  344. Public Health Institute
  345. Public Housing Relocations: Impact On HIV Risk And Drug Use
  346. Quality, Economic Outcomes, and Sustainability of Telepsychiatry (QUEST)
  347. Rapid Development and Deployments of Non-Physician Providers In Critical Care
  348. Reducing Alcohol-Related HIV Risk in African American Females
  349. A Regionally Coordinated Intervention to Reduce Racial Disparities in Access to Ki
  350. RWJF-State-Level Benefits of Reducing Cardiovascular Disease Risk Factors
  351. Substance Abuse and Mental Health Services Administration's (SAMHSA) Minority Fell
  352. SD Tobacco Prevention Webinar Series 2012 - 2013
  353. Services for Adolescents and Adults With Autism Spectrum Disorders
  354. In Silico Research Center of Excellence - Extension
  355. STD/HIV Prevention Training Center
  356. Stress and Drug Use Vulnerability in the African American Community
  357. Support the Water, Sanitation and Health Programme of WHO Guidelines
  358. Surveillance, Epidemiology and End Results (SEER)
  359. Sustainable Access to Safe Water at Health Facilities
  360. TEPHINET-Leadership and Health Systems Strengthening Training
  361. The Challenge of Individualizing Treatment For Patients With Breast Cancer
  362. Toward Improved Long-Term Outcome In Classic Galactosemia
  363. Training In The Population Biology of Infectious Disease
  364. Training in Interventions to Improve Outcomes in Chronic Conditions
  365. Training Program in Academic Pulmonary Medicine
  366. Understanding Child Mental Health Services in the Public Safety Net
  367. The VA Diabetes Review Merit
  368. View Point Health
  369. Vitamin D Status and HIV-Related Complications In Children and Young Adults
  370. Women's Empowerment & Intimate Partner Violence in Bangladesh
  371. 00103311 A Phase 3, Randomized, Open Label Study Investigating the Efficacy of the
  372. 0113-CL-1004: A Randomized, Double-blind, Placebo-controlled, Phase 3 Trial to Evaluate
  373. 10-392 Absorb III Randomized Controlled Trial
  374. 14861B: An Open-label Extension Study to Evaluate the Long-term Safety
  375. 156-08-276 A Phase 3b, Multicenter, Open-label, Randomized Withdrawal Trial of
  376. 15-AVP-786-302: A Phase 3, multicenter, randomized, double-blind, placebo-controlled
  377. 165-302 - A Four-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four
  378. 18F Conjugated Maltrodextrins for the Detection of Medical Device Infections
  379. 2015 - 2016 Cystic Fibrosis Care Center
  380. 2015 - 2016 Cystic Fibrosis Care Center
  381. 2015 AAMC Accelerating Health Equity, Advancing through Discovery (AHEAD)
  382. 2015 AVON Center of Excellence
  383. 2016-17 GA Child Welfare Legal Academy
  384. 2016-2017 Governor's Office of Children and Families Contract
  385. 2016 Georgia Department of Aging Services Contract
  386. 2016 Georgia Emerging Infections Program (EIP)
  387. 2016 Georgia Emerging Infections Program (EIP)
  388. 2016 Health Career Academy Program Grant
  389. 2016 Health Policy Research Scholars Fellowship
  390. 2016 International Emory Global Health Case Competition
  391. 2017 Annual Health Economics Conference Grant
  392. 221AD302: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled
  393. 2/2- Regional Geohealth Hub centered in Peru-US
  394. 261203 BAX855 PUP: Phase 3, prospective, multi-center, open label study to investigate
  395. 54767414MMY3003: Phase 3 Study Comparing Daratumumab, Lenalidomide
  396. 6002-018: A Phase 3, Long-term, Open-Label Study of Istradefylline in Subjects with
  397. A5481008 a randomized, multicenter, double-blind phase 3 study of
  398. AAKP Fabry Family Testing Project
  399. AbbVie P11-292 Cape Registry
  400. AC220-007 A Phase 3, Open-Label, Randomized Study of HSCT Consolidation
  401. Accelerating Change in Medical Education
  402. ACE-536-MDS-001A: Phase 3 study to compare Luspatercept v Placebo
  403. Achieving Universal Access to Urban Sanitation Services Workshop
  404. A Comprehensive Pre-natal Intervention to Increase Vaccine Coverage
  405. A Comprehensive Pre-natal Intervention to Increase Vaccine Coverage
  406. ACOSOG Z4099/RTOG 1021: A Randomized Phase III Study of Sublobar Resection
  407. A Cross-Sectional Analysis of Cardiovascular Disease in the Hemophilia Population
  408. Acrostudy: a Multicenter, Post Marketing Surveillance Study of Pegvisomant Therapy
  409. Accuracy of SEER diagnosis date: SEER-Medicare
  410. Adjuvant chemotherapy for breast cancer in patients with schizophrenia
  411. The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening
  412. Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer
  413. Association between the availability of medical oncologists and receipt of chemotherapy
  414. The association of insurance and stage at diagnosis among patients aged 55-74 in the National Cancer Database.
  415. Breast and colorectal cancer survivorship care barriers
  416. Breast Cancer Estrogen and Progesterone Receptor Status and Country of Origin in black women in the United States SEER
  417. Breast cancer patient surveillance after curative-intent primary treatment
  418. Changes in treatment for oropharyngeal cancer over time.
  419. Cholecystectomy in patients with prior ventriculoperitoneal shunts
  420. Comorbidity and treatment for advanced stage laryngeal cancer - NCDB
  421. Comorbidity and receipt of chemoRT vs surgery among laryngeal cancer patients
  422. Compare comorbidities in NCDB to matched Medicare data
  423. Comparison of case counts and patient characteristics between NCDB and CINA Delux ¿ Other
  424. Data sources for cancer survivorship research: MEPS
  425. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations
  426. Disparities in stage at diagnosis and treatment among adult testicular germ cell tumor patients
  427. The effect of pre-treatment patient characteristics on the allocation of treatment for advanced epithelial ovarian cancer
  428. Estimating the economic burden of cancer survivorship in the United States
  429. Global patterns of esophageal, stomach and GE junction cancers
  430. Guideline adherence in the diagnosis and treatment of patients with non-small cell lung cancer (PCE)
  431. Hospital characteristics predictive of surgery for non-small cell lung cancer
  432. The impact of healthcare reform on cancer patient
  433. Impact of health care reform legislation on uninsured and medicaid-insured cancer patients.
  434. Impact of Medicaid-enrollment status/timing on stage at diagnosis
  435. Improved survival is associated with treatment at high volume teaching facilities for patients with advanced stage laryngeal cancer
  436. Insurance status and racial differences in uterine cancer survival
  437. Insurance status and age are predictors of late stage at diagnosis among cervical cancer patients in the National Cancer Data Base
  438. Insurance status, comorbidity level, and survival among colorectal cancer patients
  439. Insurance status and survival disparities among nonelderly rectal cancer patients in the National Cancer Data Base.
  440. Insurance status and survival among adolescents and young adults with cancer
  441. Medical Expenditures Panel Survey (MEPS)
  442. MEPS cancer survivor enhancement
  443. Neoadjuvant chemoradiation for stage III NSCLC
  444. Nursing home characteristics and utilization of cancer-related medical services
  445. Nursing home and hospice utilization
  446. Ovarian cancer patient surveillance after curative-intent initial treatment.
  447. Patterns of extralaryngeal spread of laryngeal cancer
  448. Patterns of neo-adjuvant chemotherapy in ovarian cancer among stage II patients
  449. Patterns of care of non-Hodgkins lymphoma
  450. Perceived and realized access to care and utilization in cancer survivors compared with individuals without cancer
  451. Persistent disparities in liver transplantation for hepatocellular carcinoma in the United States
  452. Persistent disparities in liver transplantation for patients with hepatocellular carcinoma
  453. Predictors of vague histological diagnosis in the National Cancer Data Base, 1998-2008
  454. Prostate Cancer Disease Severity and Country of Origin in black men in the United States SEER
  455. Race and ethnicity are associated with delays in breast cancer treatment
  456. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
  457. Racial disparities in stage-specific colorectal cancer mortality rates, 1985-2007
  458. Racial, ethnic and socioeconomic health disparities among cancer survivors and informal caregivers.
  459. Referral patterns for colorectal cancer patients undergoing chemotherapy
  460. Reporting of quality initiatives for oral cavity cancer
  461. Survival of oropharyngeal cancer - NCDB
  462. Temporal trends in treatment of early and advanced laryngeal cancer
  463. Testicular cancer patterns of care
  464. Transoral Robotic Surgery (TORS)
  465. Treatment of cancer of the larynx and side effects of such treatment ¿ SEER Medicare
  466. Treatment of muscle invasive bladder cancer
  467. Trends in esophageal cancer treatment-NCDB
  468. Trends in mortality from oral cavity and pharyngeal cancer
  469. Trends in stomach cancer treatment-NCDB
  470. ACS -HPV Qualitative Analysis
  471. ACTG Underrepresented Populations Committee Support
  472. ACTG Women Outreach Worker (WOW)
  473. Adapting an Intervention to Promote Healthy Eating and Prevent Weight Gain among 2
  474. Adapting an Intervention to Promote Healthy Eating and Prevent Weight Gain among 2-1-1 Clients Through Improved Home Food Environments
  475. Adapting Promoting and Disseminating Evidence-based Epilepsy Self Management Program
  476. Adapting Promoting and Disseminating Evidence-based Epilepsy Self Management Programs
  477. AdaptResponse Clinical Study
  478. Addressing disparities in breast healthcare
  479. Addressing Prostate Cancer Information Disparities with eHealth Technology
  480. Addressing the Needs of Metastatic Breast Cancer Patients via Patient Navigation
  481. Adjuvant Axitinib Treatment of Renal Cancer: A Randomized Double-Blind Phase 3 Study
  482. Adolescent Medicine Trials Network for HIV/AIDS
  483. A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a Monoaminergic Antidepressant in Adults with Major Depressive Disorder
  484. ADS-AMT-PD302 Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extension
  485. Advancing mHealth using Big Data Analytics: Statistical and Dynamical Systems Models
  486. Advancing National Public Health Institutes Globally
  487. Advancing National Public Health Institutes Globally
  488. Adverse Effects of RBC Transfusions: A Unifying Hypothesis
  489. a Facilitated Access Program to Provide Everolimus (RAD)
  490. A Framework of VPD Burden and Impact Assessment
  491. African Ancestry Genomic Psychiatry Cohort
  492. African Health Workforce Project
  493. African Health Workforce Project
  494. Age of Blood in Children in Pediatric Intensive Care Units
  495. Age of Blood in Children in Pediatric Intensive Care Units
  496. A Geospatial Approach to Target HIV-Infected Populations Poorly Engaged in Care
  497. A Global, Multi-Center, Long-Term, Observational Survey
  498. AIDS Clinical Trial Group Network
  499. AIDS Clinical Trial Group Network
  500. AIDSVu
  501. Air Quality Research Emory-Niteen (PR20829037)
  502. Comparing Albumin and Hetastarch Therapy in Acute Lung Injury
  503. Comparative Effectiveness of Albumin vs. Saline for Resuscitation in Septic Shock
  504. All Cause Mortality 1-30 Years After Interventions for Congenital Heart Diseases
  505. Alliance for a Healthier Generation
  506. Alliance for Reducing Cancer Northwest SIP 09-002
  507. ALX0681-C301: Phase III Study of the Efficacy and Safety of Caplacizumab
  508. ALXN1210-aHUS-312; A Phase 3, Open-Label, Multicenter Study of ALXN1210 in Children
  509. Alzheimer's Association Curriculum Development
  510. Alzheimers Disease Neuroimaging Initative-2 (ADNI-2)
  511. Ambient air pollution and respiratory outcomes
  512. Amgen 3B-ITP: A Single Arm, Open-label, Long-term Efficacy and Safety Study of
  513. A Mobile Phone Game to Prevent HIV Among Young Africans
  514. A Mobile Phone Game to Prevent HIV Among Young Africans
  515. A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial
  516. A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX® Compared To Autogenou
  517. A Multi-center Group to Study Acute Liver Failure in Children
  518. A Multi-Center Prospective Long-term, Observational Reg
  519. A Multi City Examination of Pollutant Components and Acute Morbidity
  520. A Multilevel Analysis of Partner Violence
  521. A multimedia, group-based clinical care and support model to increase dual protect
  522. A Multisite Neurobehavioral Assessment of Fetal Alcohol Spectrum Disorders
  523. Analytical Methods for Estimating the Joint Climatological-social Drivers of Water
  524. A National Coordinating Center for Pre-Hospital Trauma Research Funding; Detection
  525. An Atlanta TrialNet Center: Building a Pathway to 70 Clinical Trial Subjects/Year
  526. ANCHOR: Anal Cancer/HSIL Outcomes Research Study
  527. ANCHOR: Anal Cancer/HSIL Outcomes Research Study
  528. An Expanded Treatment Protocol of Panobinostat (LBH589)
  529. An Extension Protocol for Multiple Sclerosis Patients who Participated in Genzyme-Sponsored Studies of Alemtuzumab
  530. An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy
  531. An Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Tolerability
  532. An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment With Velaglucerase Alfa on Bone-related Pathology
  533. an Open-Label, Prospective, Post-Market, Historically
  534. An Open-Label Extension and Safety Monitoring Study of Patients with Moderately to Severely Active Crohn's Disease
  535. Answer ALS
  536. Answer ALS
  537. Antimicrobial Resistance and Therapeutic Discovery Training Program
  538. An Unbiased Approach to Identify Risk Factors Associated with Diarrheal Disease
  539. a Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the
  540. A Phase 3, Randomized, Double-blind Study to Evaluate the Safety and Efficacy
  541. a Phase 3, Randomized, Open-label, Active Controlled, Multicenter Study to Evaluate
  542. A Phase 3b, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study
  543. A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety
  544. a phase 3 double-blind, randomized, placebo-controlled study to evaluate the safety
  545. a Phase 3 Randomized, Double-masked, Controlled Trial
  546. A phase 3 randomized, multicenter, multinational, double-blinded study (COMET)
  547. A Phase 4, Multicenter, Open-label Study of Serum Infliximab Concentrations and Efficacy and Safety of Dose Escalation in Pediatric Patients With Inflammatory Bowel Disease
  548. A Phase III Randomized Trial of Lobectomy vs Sublobar
  549. A Phase IV, Multicenter, Open-Label Study of the Immunogenicity of Nutropin AQ® V1.1 [Somatropin (rDNA Origin) Injection] Administered Daily to Naïve Growth Hormone-Deficient Children (iSTUDY)
  550. A Phase 4 Multi-Center, Ascending Dose, Open Label Study to Determine the Pharmacokinetics of Phenylephrine and the Pharmacodynamic Effects on Blood Pressure
  551. Applied MCH Epidemiology PhD Training Program
  552. A Practice-Provider-Parent-Adolescent intervention to increase HPV vaccination
  553. A Practice-Provider-Parent-Adolescent Intervention to Increase HPV Vaccination
  554. A Proposal to Establish the Morehouse/Emory Cardiovascular (MECA) Center for Health
  555. CMX001-333 A Prospective Observational Study for the Long-term Follow-up of Subjects
  556. A Prospective Observational Study for the Long-term Follow-up of Subjects Previous
  557. AR22.001 VIGILANT Registry: A Multicenter, Observational Registry to Collect Information
  558. A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination
  559. P10-3 (PROCEED Trial) - A Registry of Sipuleucel-T Therapy in Men w/ Advanced Prostate Cancer
  560. A Rigorous Evaluation of the Relationship between Physical Activity and Education
  561. Arkansas Tobacco Prevention and Cessation Program
  562. ARRAY 520-001: An Open-label, Multicenter Rollover Study to Allow Continued Access
  563. A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic
  564. Assessing HIV Risk and Prevention Locations among Men who have Sex with Men
  565. Assessing HIV Risk and Prevention Locations among Men who have Sex with Men
  566. Assessing the Accuracy of the Technology-based Eye Care Services (TECS) Protocol to a Standard Clinical Ophthalmic Exam
  567. Assessing the Health Impact and Cost of the Gram Vikas Sanitation Program
  568. Assessing the impact of home fortification of complementary foods on child cognitive development
  569. Assessment of Fecal Exposure Pathways in Low-Income Urban Settings
  570. Association of persistent organic pollutants with incident diabetes in India
  571. Association of Persistent Organic Pollutants with Incident Diabetes in India
  572. Associations between Delivery Hospital Obstetric Service Level and Selected Maternal and Perinatal Outcomes for High Risk Women
  573. A Stratified, Post-Market Study of DeNovo® NT for Treatment of Femoral and Patella
  574. a study to improve the fit of hiv prevention methods
  575. A Survey Experiment to Understand Sexual Violence Disclosure Among College Women
  576. AT1001-042: An open-label extension study to evaluate the long term safety and
  577. ATHN 4: VTE QI Project: Transition of Care for Patients with Venous Thromboembolis
  578. Atlanta Clinical and Translational Science Institute - KL2
  579. Atlanta Clinical and Translational Science Institute (UL1)
  580. Atlantic Coast Consortium for Asthma
  581. Atrial fibrillation: Epidemiology, Prevention, and Outcomes
  582. Atrial fibrillation: epidemiology, prevention, and outcomes
  583. A Trial of Opening Doors to Recovery for Persons with Serious Mental Illness
  584. Audio-Haptic Virtual Environments for Large-Scale Navigation in the Blind
  585. Augmentation Versus Switch: Comparative Effectiveness Research
  586. A Unified Clinical Genomics Database
  587. A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens
  588. A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens
  589. Autism Genetics, Phase II: Increasing Representation of Human Diversity
  590. Award for a Mental Health Coordinator
  591. A widespread self-management education program to reduce health disparities in African American women with systemic lupus erythematosus
  592. A Widespread Self-management Education Program to Reduce Health Disparities
  593. AXS-05-301: A Randomized, Double-blind, Active-controlled Trial to Assess the
  594. B1931022 - B1931022: An Open-label Randomized Phase 3 Study of Inotuzumab Ozogami
  595. B5201002 a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled
  596. B5201002: A Phase 3 Study to Evaluate Rivipansel-Sickle Cell Disease
  597. B9991001: Phase 3 Study of Avelumab* (Msb0010718c)
  598. B9991003: Phase 3 Study of Avelumab (MSB0010718C) in Combination with Axitinib
  599. B9991010 - A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the
  600. Barriers to tuberculosis preventive treatment in patients with newly diagnosed diabetes mellitus and latent tuberculosis infection
  601. Barriers and Facilitators of Optimal Care for Male Factor Infertility
  602. BAY 1841788 /177777:Phase III study of ODM-201 versus placebo prostate cancer pts.
  603. BAY59-7939/39039039STM4001/1862 : Phase 3b Rivaroxaban Prophylaxis Compared with
  604. Bay 88-8223 / 15396 A phase III trial of radium-223 dichloride
  605. Behavioral Health Provider - School Based Health Centers
  606. Belimumab (HGS1006) in Adult Subject of Black Race with SLE
  607. BH29884-ACE910-A Randomized, Multicenter, Open-label, Phase III Clinical Trial
  608. Biobehavioral Determinants of the Microbiome and Preterm Birth in Black Women
  609. Biobehavioral Determinants of the Microbiome and Preterm Birth in Black Women
  610. Biological and Socio-Cultural Determinants and Management of Cardiovascular Health
  611. Biological Mechanisms of Stress Disorders Co-Morbid with HIV in African Americans
  612. BioMarin Biobank
  613. Biomarkers and the Development of Acute Chronic Diseases
  614. Biotest 988: A Multi-Center, Randomized, Prospective, Open-Label Phase III Study
  615. Blinded Long-term Extension Study to Evaluate the Safety and Efficacy of Pioglitazone
  616. BN29552: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled
  617. BO25323/CLL14: A prospective, open-label, multicenter, randomized phase III trial
  618. BO28984 ALEX Randomized, multicenter, phase 3, open label study of Alectinib
  619. Bosutinib Extension-An Open-label Bosutinib Treatment Extension Study for Subjects
  620. BRCA Educational Program for the Ashkenazi Jewish Community
  621. BRF115532 - COMBI-AD: A phase III randomized double blind study of dabrafenib
  622. Bridging the Grady GAP - Genetic Access Program for Individuals at Risk for Hereditary Breast Cancer
  623. Building Capacity to Control Viral Food Borne Disease: A Translational, Multidisciplinary Approach
  624. Building the Capacity of Lay Health Professionals to do Pediatric Vision Screenings
  625. Burden of Lupus Comorbidities Derived from the Georgians Organized Against Lupus
  626. Burden of Lupus Comorbidities Derived from the Georgians Organized Against Lupus
  627. C16014 A Phase 3 Study Comparing Oral MLN9708 versus Placebo Plus Lenalidomide
  628. C16021: Phase 3 Study of Oral Lxazomib Maintenance Therapy
  629. C87075: SECURE Registry Study
  630. CA204006 - A Phase 3, Randomized, Open Label Trial of Lenalidomide/dexamethasone
  631. CA204143: An Expanded Access Program for Elotuzumab in Combination with Lenalidomid
  632. CA209025: A Randomized, Open-Label, Phase 3 Study of BMS-936558 vs Everolimus
  633. CA209-026: An Open-Label, Randomized Phase 3 Trial of Nivolumab versus Investigato
  634. CA209067 -A Phase 3, Randomized, Double-Blind Study of Nivolumab Monotherapy combination
  635. CA209-141-0001 An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs
  636. CA209-168 Expanded Access Program with Nivolumab for Subjects with Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Systemic Treatment Containing an Anti CTLA-4 Monoclonal Antibody
  637. CA209-204: Study to Evaluate Safety and Efficacy in Subjects with Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy
  638. CA209-214 A Phase 3, Randomized, Open-Label Study of Nivolumab
  639. CA209-218 Expanded Access Program with Nivolumab (BMS-936558)
  640. CA209-227: An Open-Label, Randomized Phase 3 Trial of Nivolumab, or Nivolumab plus
  641. CA209-238: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy
  642. CA209-331: An Open-label, Randomized, Phase 3 Study of Nivolumab or Chemotherapy
  643. CA209-451: A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab
  644. CA209-498: Phase 3 Study of Nivolumab-vs-Temozolomide
  645. CA209-602: Phase 3 Trial of Combinations of Nivolumab, Elotuzumb, Pomalidomide & Dexas
  646. CA209-648: Phase 3 Study of CheckMate 648- Esophageal Squamous Cell Carcinoma
  647. CA209-651:Phase III Study of Nivolumab vs Extreme Study Regimen (SCCHN)
  648. CA209-817: Phase IIIb/IV Trial of Flat Dose Nivolumab w/ Ipilimumab
  649. CA209-915: Phase 3 Study of Immunotherapy after resection of Stage 3 or 4 Melanoma
  650. CA209920:Phase 3b/4 Trial of Nivolumab Combined with Ipilimumab
  651. California Smoke Free Homes-Adapting Smoke-Free Homes Print Materials for American
  652. Can a Fitbit Increase Postoperative Ambulation of Colorectal Surgical Patients
  653. Cancer Data Quality Patterns
  654. Cancer Registry/Tracking Measures of Care
  655. Cancer and Screening Correlates in India's Nationwide Survey
  656. CANOPY: Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
  657. CareDx Registry Sub-Study: Protocol SN-C-00004
  658. Caregiver Stress
  659. Care of the Adult Cystic Fibrosis Patient
  660. Carepartner- Integrated Telehealth Rehab Program for Persons with Stroke
  661. Carepartner- Integrated Telehealth Rehab Program for Persons with Stroke
  662. CARRA REGISTRY: Observational Study of Pediatric Rheumatic Diseases
  663. Carter Consulting Tobacco Expert
  664. CA SFH: United Indian Health Services
  665. CA SFH: United Indian Health Services
  666. CASK: Controlling and Preventing Asthma Progression and Severity in Kids
  667. Catalyst EAP-001-Amend 3-An Open-Label, Expanded Access Protocol for Firdapse
  668. CBKM120F2303 - A phase III randomized, double blind, placebo controlled study of
  669. CDC Sub:Zika Diagnostics Development: Diagnosing recent and Remote Zika Infections
  670. Cellular Diversity and Clinical Relevance of Stem Cells in Pancreatic Cancer
  671. Center for AIDS Research at Emory University
  672. Center for AIDS Research at Emory University
  673. Center for Children's Health, the Environment, the Microbiome, and Metabolomics
  674. Center for Children's Health, the Environment, the Microbiome, and Metabolomics
  675. Center for Prevention Implementation Methodology for Drug Use and HIV
  676. Center For Statistics and Quantitative Infectious Diseases
  677. Center for Statistics and Quantitative Infectious Diseases
  678. Center for the Health of Incarcerated Persons/Successful Linkages
  679. Center for the Health of Incarcerated Persons/Successful Linkages
  680. Center of Excellence in MCH Education, Science, & Practice
  681. Ce-PIM for Drug Abuse and Sexual Risk Behavior
  682. CF Atlanta Cystic Fibrosis Research and Development Program
  683. Change Starts At Home Project
  684. Characterization of Heat-Related Illness in Central Florida Farmworkers
  685. Characterization of Skin Cancer Risk Factors and Screening in Sexual Minority Populations
  686. Characterizing Cognition Across the Lifespan in Untreated Psychosis in China
  687. Chemical Safety During Breast Cancer Susceptible Windows
  688. Chemotherapy adherence in decision making in early stage breast cancer
  689. Child Health and Mortality Prevention Surveillance (CHAMPS) Network
  690. Child Health and Mortality Prevention Surveillance (CHAMPS) Network
  691. Childhood Adversity and Cardiovascular Health among Puerto Rican Youth
  692. Childhood SES Factors: Impact on Age-related Cognitive and Vascular Health
  693. ChiLDReN: Childhood Liver Disease Research Network FORCE Protocol, v 1.1
  694. Analysis of neonatal admissions at CHOA: pilot proposal for the Birth and Neonatal Outcomes CORPH
  695. The B.R.A.I.N Program
  696. EPA Clean Air Research Center
  697. Follow-up of Acquired Brain Injuries in Preschool Children
  698. Health Impact Assessment of Ambient Air Pollutants
  699. Language and Literacy Outcomes of Preschool Children with Traumatic Brain Injuries
  700. Multicenter Network of Neonatal Intensive Care Units
  701. National Children's Study
  702. Optimizing Value of Emergency Department Care: Impact of Physician Feedback Using a Composite Quality and Resource Use Metric
  703. Pathophysiological mechanisms of autism risk in patients with 22q11 deletion syndrome
  704. PBDE Body Burdens, House Dust Concentrations and Associations with Thyroid Hormones in Children Age 2-5 Years
  705. Post-licensure pneumococcal carriage study for a new pneumococcal conjugate (PCV13) vaccine
  706. Prevalence and Correlates of HPV vaccination in Rural Georgia
  707. Schizophrenia biomarkers discerned by cellular networks in DiGeorge syndrome
  708. Schizophrenia Heterogeneity and Toxoplasma Exposure
  709. Study on the scope and causes of stillbirth
  710. Using cell phones as cognitive prosthesis to enhance memory and organization in teens with acquired brain injuries
  711. Chronic Stressors, Brain Vasculature, and Cognitive Function in African-American
  712. Clinical Decision Support Systems for Effective Management of Patients with Barrett¿s Esophagus using Optical Endomicroscopy
  713. Clinical Epidemiology
  714. Clinical Coordination Center for STEADY-PD Phase 3 Study
  715. CMS-001-A Phase 3, Multicenter, Double-blind, Placebo-controlled, Randomized, Outpatient
  716. Co-authorship grant: Health as an Economic and Political Currency
  717. Collaborative Islet Transplant Registry (CITR)
  718. Collaborative Research and Action: Empowering an Exposed Community
  719. Collaborative Research: Food insecurity and mental health in global perspective
  720. Colorado Center for Childhood Liver Disease Research Network
  721. Colorado Center for Childhood Liver Disease Research Network
  722. Colorectal Chemoprevention with Calcium and Vitamin D
  723. Combating Childhood Illness Seed Grants
  724. Community-based participatory research with community workers and health providers in the Dominican Republic
  725. Community Counts: Public Health Surveillance for Bleeding Disorders
  726. Community Counts: Public Health Surviellance for Bleeding Disorders
  727. Community Influences on Female Genital Mutilation/Cutting in Africa
  728. Community VOICES 3: Views on Informed Consent in Emergency Situations
  729. Comparative Effectiveness in the Diagnosis of von Willebrands Disease VWD
  730. Comparative Effectiveness in the Diagnosis of von Willebrands Disease VWD
  731. Comparative Effectiveness of Modern Therapies for Localized Prostate Cancer
  732. Comparative Effectiveness of Oral Anticoagulants in Atrial Fibrillation
  733. Comparative Risks and Benefits of Gender Reassignment Therapies
  734. Comparing Behavioral Assessments Using Telehealth for Children with Autism
  735. Comprehensive HIV Services for Key Populations in Rwanda
  736. Comprehensive HIV Services for Key Populations in Rwanda
  737. Conflict Resolution Training
  738. Connect Registry
  739. Continued Access to Prevail (CAP2)
  740. Coordinated Care for IPV Survivors through the M Health Community Network
  741. Core Clinical Consortium for Blood and Marrow Transplant Clinical Trials Network
  742. Cost burden of treatment resistance in patients with depression
  743. Cost Effectiveness and Quality of Life
  744. CP2011-1 (ABLATE PAS): Atricure Synergy Ablation Lesions for Non-Paroxysmal Forms
  745. CP-4-006_OPKO Genotropin; a Phase 3, Open-label, Randomized, Multicenter
  746. CPP FAP-310: A Double Blind, Randomized, Phase III Trial of the Safety and Efficacy
  747. Creating and Validating Child Adverse Event Reporting in Oncology Trials
  748. Creating Evidence Base for Determinants of Maternal Immunization Acceptance
  749. Creating Evidence Base for Determinants of Maternal Immunization Acceptance
  750. Creation of Newborn Screening (NBS) Tyrosinemia Connect
  751. Creation of Newborn Screening (NBS) Tyrosinemia Connect
  752. Critical Care Training Program
  753. Critical Care Training Program
  754. Cross-Cultural Insights into Well-being among Vulnerable Populations
  755. Cross Training DAS
  756. Cardiothoracic Surgery Network
  757. CT Dose Collaboratory
  758. CT Dose Collaboratory
  759. CTH-300: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group
  760. CTH-301: An Open-Label, Phase 3 Study Examining the Long-Term Safety, Tolerability
  761. CT Perfusion to Predict Response to Recanalization in Ischemic Stroke Project
  762. CureGN: Cure Glomerulonephropathy Network
  763. Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients
  764. CVCT Plus: A couples-Based Approach to Linkage to Care and ARV
  765. CVCT Plus: A Couples-Based Approach to Linkage to Care and ARV
  766. CVT-301-004: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
  767. D4191C00001 (PACIFIC) A Phase III, Randomized, Double-blind, Placebo-controlled
  768. D4191C00004 (ARCTIC) A Phase III, Open-Label, Randomised, Multi-center, International
  769. D4193C00002: A Phase III Randomized, Open-Label, Multi-Center, Global Study of MED
  770. D419BC00001: Phase III Study of First-Line MEDI4736 in Patients w/Stage IV Bladder
  771. D419LC00001: A Phase III Randomized, Open-label, Multi-center, Global Study of MED
  772. D5160C00003 (AURA3): A Phase III, Study of AZD9291 versus Platinum-Based Doublet
  773. Dana Robinson-Health Policy Research Scholarship Program
  774. Data to Care Challenges (D2C) RSS IDIQ RFTOP
  775. Deciphering the Treatment Risks: a Decision Support Tool for Transplant Candidates
  776. Decision Aid: Comparative Effectiveness of a Decision Aid for Therapetuic Options
  777. Decisional Quality for Patients with Stable Coronary Artery Disease
  778. Decisional Quality for Patients with Stable Coronary Artery Disease
  779. Deep Learning and Streaming Analytics for Prediction of Adverse Events in the ICU
  780. Deep Learning and Streaming Analytics for Prediction of Adverse Events in the ICU
  781. Defining the rectal mucosa in MSM at risk of HIV infection
  782. Delay Discounting and HIV Sexual Risk Behavior in Men who Have Sex with Men
  783. Dengue Virus Infection in India
  784. Design and Assessment of a Program to Integrate Key Hygiene Behaviors
  785. Design and Assessment of a Program to Integrate Key Hygiene Behaviors Within a Mat
  786. Designing, Implementing and Evaluating Low-cost Interventions to Improve Latrine
  787. Designing an HIV Prevention Curriculum for Migrant Farmworkers in Georgia
  788. Developing and Testing Novel Therapies for the Alcoholic Lung: Our Clinical Trials
  789. Developing ASHA: A Community Based Coalition to Prevent Diabetes among South Asian
  790. Development and Assessment of Decision Supporting System for Renal Studies
  791. Development of a HIV Prevention Toolkit for at-risk HIV-negative Male Couples
  792. Development of Point of Care Diagnostics for Norovirus
  793. Development of the WHO Guidelines on Sanitation and Health (PO 201408311)
  794. Diabetes Prevention Program Demonstration Projects - McKenna
  795. DiaSys: Computerized Decision Support to Improve Diabetes Management in Primary Care
  796. Diffusion of Tobacco Control Fundamentals to Other Large Chinese Cities
  797. DIGEST Program Emory University/Children's Healthcare of Atlanta
  798. Disparities in the Utilization of Emergency Department Computed Tomography
  799. Distinguishing Medical Marijuana Use From Recreational Use Among Young Adults: Addressing a Critical Issue in Healthcare
  800. Does stanniocalcin predict late breast cancer recurrence, or is it a fish story?
  801. Dopamine enhancement of fear extinction learning in PTSD
  802. DOT Diary (D2): Developing a Mobile App with Combined Automated DOT and Daily Sexual
  803. DOT Diary (D2): Developing a Mobile App with Combined Automated DOT and Daily Sexual
  804. Double-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
  805. Down Syndrome Cognition Project (DSCP)
  806. DU176b-D-U311: A Phase 3b, Prospective, Randomized, Open label, Blind Evaluator
  807. E7389-G000-309 - A Randomized, Open-Label, Multi-Center, Phase III Study to Compare
  808. Emory Alcohol and Lung Biology Center
  809. Early Childhood Nutrition and Adult Metabolomic and Cardiometabolic Profiles
  810. Early Childhood Nutrition and Adult Metabolomic and Cardiometabolic Profiles
  811. Early Identification of Affected Children and Risk Factors for FASD in Ukraine
  812. Eat, Move, Talk
  813. Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk
  814. Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk
  815. Emory Center for Injury Control
  816. Economic Consequences of Advanced Testing for Subclinical Cardiovascular Disease
  817. Economic and policy assessment regarding the impact of changes to state laws regar
  818. Economic and Policy Assessment Regarding the Impact of Changes to State Laws Regarding SOPs for Certified Nurse Midwives
  819. Economic evaluation of laser ablation procedures performed with the ClearPoint system
  820. EDRN: Biomarkers and Clinical Parameters Associated with Gleason Score Upgrading
  821. Effectiveness of combination HIV preventive interventions for young Thai MSM
  822. Effectiveness of Functional Strength Training in Virtual Reality Games for Improving Arm Function in Children with Cerebral Palsy ¿ A Pilot Sequential Multiple Assignment Randomized Trial (SMART) Design
  823. Effect of School-Based Health Centers on Reducing Students Health Disparities
  824. Effect of School-Based Health Centers on Reducing Students Health Disparities
  825. Effects of Exercise on Epigenetic Pathways in Persons with Heart Failure
  826. Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
  827. Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer
  828. Efficacy and Immunogenicity of Tdap Immunization of Pregnant Women for Preventing Pertussis in Early Infancy
  829. EHR-based Universal Medication Schedule to Improve Adherence to Complex Regimens
  830. Electronic Consent for Biobanking
  831. Emergency Department Overcrowding
  832. Emory Autism Center 2016-2017 Contract
  833. Emory Center for Public Health Training in Complex Humanitarian Emergencies
  834. Emory Center for Public Health Training in Complex Humanitarian Emergencies
  835. Emory-Georgia TB Research Training Program
  836. Emory Neuro Developmental Exposure Clinic (ENEC)
  837. Emory Partnership for Global Health Security Training (Emory PGHST)
  838. Emory Partnership for Global Health Security Training (Emory PGHST)
  839. Emory PERRC: Translation, Dissemination, and Implementation of Public Health Preparedness
  840. Emory Pipeline Collaborative (EPiC)
  841. Emory Pipeline Collaborative (EPiC)
  842. Emory WIHS CRS - Longitudinal Cohort
  843. Emotional Stress as a Risk Factor for Arrhythmia: Ischemic and Genetic Mechanisms
  844. Emotional Stress as a Risk Factor for Arrhythmia: Ischemic and Genetic Mechanisms
  845. Empower Minorities in Health Through Mobile App Education and Community Engagement
  846. Enabling Factors for Promoting HIV Pre-Exposure Prophylaxis (PrEP) among Healthcare Providers: A Qualitative Study of Active PrEP Prescribers in Georgia
  847. End-of-Life in Assisted Living: Links between Structure, Process, and Outcomes
  848. End-of-Life in Assisted Living: Links between Structure, Process, and Outcomes
  849. Engaging Adolescents and Community Youth Advocates in Adolescent Health Outcomes
  850. Engaging Patients with Mental Disorders from Emergency Departments into Outpatient Care
  851. Enhanced Entomological Surveillance of Aedes Aegypti In the Context of Dengue, Chikungunya and Zika Transmission
  852. Enhancing Clinical Meaningfulness and Usefulness of PROMIS Pediatric Measures
  853. Enhancing Exposure Therapy for PTSD: Virtual Reality
  854. Enhancing Linguistic Competency at Clarkston Community Health Center
  855. Enhancing Models of HIV, Viral Hepatitis, STIs, and Tuberculosis to Inform
  856. Enhancing models of HIV, viral hepatitis, STIs, and tuberculosis to inform and imp
  857. HPTN 078: Enhancing Recruitment, Linkage to Care & Treatment for HIV-Infected MSM
  858. ENLiST Registry-Evaluating Nulojix Long Term Safety in Transplant-Observational Studies
  859. Environment, Epigenetics, Neurodevelopment & Health of Extremely Preterm Children
  860. Environmental Approaches to Prevention
  861. Epic Observational Study
  862. Epidemiologic Study of Impaired Decision-Making in Preclinical Alzheimer's Disease
  863. Epigenetic and Biobehavioral Determinants of Preterm Birth in Black Women
  864. Epigenetic and Biobehavioral Determinants of Preterm Birth in Black Women
  865. Epigenetic Mechanisms of Inflammation and Fatigue in Head and Neck Cancer Patients
  866. Ethics in Resuscitation Research
  867. E-TRAIN Emergency Training for Response and Improved Nutrition
  868. E-TRAIN Emergency Training for Response and Improved Nutrition
  869. Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
  870. Evaluate, Enhance, and apply Aura Products in Public Health Tracking
  871. Evaluate and Enhance Suomi Products for Air Quality and Public Health Applications
  872. Evaluate and Enhance Suomi Products for Air Quality and Public Health Applications
  873. Evaluating ART for All HIV Seropositives: Can it work with the hardest cases?
  874. Evaluating ART for ALL HIV Seropositives: Can it work with the hardest cases?
  875. Evaluation of national aids fund initiatives
  876. Evaluation of Approaches to Reduce Adverse Birth Outcomes in Georgia
  877. Evaluation of Approaches to Reduce Adverse Birth Outcomes in Georgia
  878. Evaluation of Rapid HIV Self-Testing among MSM in High Prevalence Cities
  879. Evaluation of the Efficacy of Vortioxetine for Posttraumatic Stress Disorder
  880. Evaluation of the Literacy Demand and Racial/Ethnic Influences for Self-Reported Symptomatic Adverse Events during Childhood Cancer Therapy
  881. Evaluation of the Two Georgias Initiative
  882. Evaluation Services for the Planning for Healthy Babies Family Planning Waiver Program
  883. Evaluation Services for the Planning for Healthy Babies Family Planning Waiver Program
  884. EVARREST: A Single-Blinded, Randomized, Controlled, Comparative Phase III Study
  885. Evidence Summary Regarding the Importance of Exposure to Poorly Managed Animal Feces
  886. Evolution of Racial Disparities in Access to Kidney Transplantation in New National
  887. Evolution of Racial Disparities in Access to Kidney Transplantation in New National
  888. Examining the Additional Hospital Inpatient Cost and Mortality Associated with Selected Hospital-Acquired Conditions
  889. Expanding Community Based Maternal Newborn Health and Nutrition Project
  890. Expanding Jail Testing for HIV
  891. Expansion of CVCT in the Copperbelt of Zambia
  892. Expectations of Discrimination and CVD risk in African-American Women
  893. Expectations of Discrimination and CVD Risk in African-American Women
  894. Exploring the Role of Community Health Workers in Improving Uptake of Family Health History Assessment Among Patients and Providers
  895. Exploring the Vaginal Microbiome, Complement Activation, and Perinatal Outcomes in African American Women
  896. Factors impacting staff nurse care coordination for hospitalized patients
  897. Failure to rescue in frail surgical patients
  898. Failure to Rescue in Frail Surgical Patients
  899. Family Economic Security Policy: Effects on Child Health Disparities
  900. Family Economic Security Policy: Effects on Child Health Disparities
  901. Family Health Initiative (FHI) in Bihar, India
  902. Feasibility, Acceptability, and Design of Real-Time Adherence Monitoring Among Young Men Who Have Sex With Men
  903. Federal Employee Worksite Health and Wellness Initiative
  904. Fellowship in Family Planning 2016-2017
  905. Fellowship in Family Planning 2016-2017
  906. Fit Body and Soul
  907. Flourishing Mental Health in Caregivers: A Mixed Methods Study of Religion
  908. Follow-Up of Newborns with Screen Positive Results for Metabolic and Endocrine Diseases
  909. Follow-up of Newborns with Screen Positive Results for Metabolic and Endocrine Disorders
  910. Formative Research to Develop and Revise an Integrated WASH and NTD
  911. Forum for Health Policy of Stockholm, Sweden and Emory
  912. Fostering Global Health Opportunities at Emory and its Partners
  913. From Watersheds to Shower Heads: A Workshop on Legionella Research and Policy
  914. MedVault
  915. Eliminating Health Disparities
  916. Gaucher Disease Outcome Survey (GOS)
  917. Generating Critical Patient-Centered Information for Decision Making in Localized
  918. Generating Long-Lived Protective Immunity Using a Universal Influenza Virus Vaccine
  919. Genetic Epidemiology of Life-Threatening Influenza Infection in Children
  920. Genetics of Lung Function and Asthma Severity in African Americans
  921. Genome Research in African American Scleroderma Patients (GRASP)
  922. Genomic Analysis of Enhanced Response to Heart Failure Therapy in African American
  923. Geography of opportunity: Neighborhood Dynamics and Child Cognitive Development
  924. Georgia Child Traumatic Stress Initiative
  925. Georgia Coverdell Acute Stroke Registry
  926. Georgia Coverdell Acute Stroke Registry
  927. Georgia Department of Public Health
  928. Georgia Department of Public Health
  929. Georgia Department of Public Health - Susan Ray
  930. Georgia Diabetes Translation Research Center
  931. Georgia Inside/Outside Child Welfare Reform Strategy
  932. Georgia Newborn Sickle Cell Newborn Screening
  933. Georgia Newborn Sickle Cell Newborn Screening
  934. Georgians Organized Against Lupus (GOAL) Cohort
  935. Georgia School-Based Health Centers Planning Grants 2016
  936. Georgia Trauma Quality Improvement Program and Surgical Quality Collaborative Proposal
  937. Global Evaluation of UNICEF's Drinking Water Supply Programming in Rural Areas & Small Towns
  938. GO29294 Phase III Study To Investigate The Efficacy And Safety Of MPDL3280A
  939. Gonococcal Isolate Surveillance Project (GISP) Regional Labs
  940. Governing Disease: Epidemics, Law, and the Challenge of Disease Control in a Demonstration
  941. GRA Venture Phase I: Dengue Fever Development Project
  942. Group Interventions for Abused, Suicidal Black Women
  943. Growth Recovery, Schooling and Cognitive Achievement: Evidence from Four Cohorts
  944. GS-US-292-0104: A Phase 3 randomized double blind study to evaluate the safety
  945. GS-US-292-0111 A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety
  946. GS-US-312-0115 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
  947. GS-US-334-1113-A Long Term Follow-up Registry for Adolescent and Pediatric Subject
  948. GS-US-337-1431 A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection
  949. GS-US-352-0101:A Phase 3, Randomized, Double-blind, Active-controlled Study
  950. GS-US-352-1214 A Phase 3, Randomized Study To Evaluate the Efficacy of Momelotinib
  951. GS-US-367-1171 - A Phase 3, Global, Multicenter, Randomized, Double-Blind, Placebo
  952. Active Design's Impact on Childhood Obesity in Affordable Housing
  953. Airborne Forward Looking Interferometer for te Detection of Terminal..
  954. ARRA: Conducting an Environmental Scan for the Health Information..
  955. ARRA: Development and Translational Assessment of a Tongue-Based Assistive Device
  956. ARRA: Providing Professional Svcs to GA Health Information Tech Ext Ctr
  957. ARRA: Systems Biological Analyses of Innate and Adapt. Responses to Vaccination
  958. Collaborative Research: Assistive Objective Manipulation Via RFID Guided
  959. Automated Macular Pathology Diagnosis in 3-D Spectral..
  960. C2 Core Data Strategy for US JFCOM J87
  961. Career: Brain-Tongue-Computer Interfacing
  962. 10Career: Fundamental Research, Design and Evaluation of Auditory and Multimodal Graphs
  963. Career: Service Distribution Equity Using Spatio-Temporal Statistical Fou..
  964. CHOA Hughes Spaulding - Sponsored GRA
  965. Sponsored GRA - CHOA Quality Assessment
  966. ClockReader for Cognitive Impairment Assessment
  967. Collaborative Research: The Center for Health Transformation I/UCRC
  968. Computational Behavioral Science
  969. Creating Effective Hospitals for America's Military
  970. Center for Health Organization Transformation Membership
  971. CT-T: Medvault - Ensuring Security and Privacy for Electronic Medical Record
  972. Davita - Sponsored GRA
  973. Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers
  974. Development and Engineering Support for the Global Federated Identity and..
  975. Echelon: Extreme-Scale Compute Hierarchies with Efficient and Locality-Optimized Nodes
  976. Emory Healthcare Nursing Research - Sponsored GRA
  977. Emory Healthcare - Sponsored GRA Program
  978. Electronic Policy Analysis and Demonstration
  979. Emory School of Medicine - Sponsored GRA
  980. Evaluation and Design of Telemedicine for Screening of Diabetic Retinopathy
  981. Evaluation and Design of Telemedicine for Screening of Diabetic Retinopathy
  982. GRA Program
  983. HCC: Small: Culture, Technology and Wellness
  984. HCC: Small: Making Health Personal: The Emerging Role of Personal Technology
  985. HCC: Medium: Accessible Aquarium Project
  986. Helping Hand
  987. H.S.I - Center for Pediatrics and Quality Outcomes
  988. Human Systems Integration Education and Training Support for AFHSIO
  989. In-Space
  990. Investigation in Mixed Integer Programming
  991. iPhone App for the Visually Impaired
  992. Leader in Healthcare Transformation
  993. Malware Analysis, Compromise Detection and Mitigation
  994. Marcus Autism Center Behavior Capture Instrumentation
  995. mediRobi: Interactive Companion for Pediatric Patients
  996. Mobile Music Touch
  997. Multi-Disciplinary Approach Pediatric Care Center
  998. Nets: Small: Wireless Multihop Networking with MIMO
  999. National Information Exchange Model (NIEM) Developmental Support
  1000. Pandemic Flu - Textile Solutions Pilot
  1001. Perkins and Will - Sponsored Grant / Internship
  1002. Phoenix Healthcare Management Systems
  1003. Radiology Process and Service Improvement
  1004. RI: Small: Temporal Causality for Video Event Analysis
  1005. A Robot for In Situ Research on Assistive Mobile Manipulation
  1006. Shepherd Center - Sponsored GRA
  1007. Sponsored GRA - DeKalb Medical
  1008. Sponsored GRA - Healthcare Program Advisors
  1009. Statcom/Care Logistics - Sponsored GRA
  1010. Robotic Combat Casualty Extraction
  1011. Supporting LSU in Creating and Excellent Evidence-Based Hospital
  1012. SWBSADIS Engineering Support
  1013. Task RT-25: Requirements for Net-Centric Enterprises (Task Under BOA 792)
  1014. Technology for Tactical and Operational Planning and Emergency Response
  1015. Vaccine Induced Immunity in the Young and Aged
  1016. Visiting Nurse Health Services - Sponsored GRA
  1017. Wireless Tracking of Tongue Movements for Wheelchair Control and Computer Access
  1018. GX29185: A Phase III, Multicenter, Randomized, Double-masked, Sham-controlled Study
  1019. HALT-Polycystic Kidney Disease
  1020. HDSA Center of Excellence at Emory University
  1021. Healing Hearts, Mending Minds in Older Persons Living with HIV
  1022. Healing Hearts, Mending Minds in Older Persons Living with HIV
  1023. Health Policy & Reform Network
  1024. Health Reform in Europe
  1025. Health Approaches for the Lymphoma Epidemiology of Outcomes Cohort
  1026. Health Disparities Proposal
  1027. Health Impact of a Climate Change Adaptation Strategy to Address Drinking Water
  1028. Health Literacy Assessment and Intervention to Reduce Disparities
  1029. Health Literacy Assessment and Intervention to Reduce Disparities
  1030. Health Literacy Labeling Project
  1031. Health Systems and Implementation Sciences Institute for NCDs in SA and LA
  1032. Healthy Beginnings System of Care Evaluation - 2017 Funding
  1033. Healthy Birth, Growth & Development Knowledge Integration Initiative (HBGDki) Target
  1034. Healthy Georgia Initiative Health Systems Mini-Grants
  1035. Healthy Georgia Initiative Health Systems Mini-Grants. HYPERTENSION. NQF 0018
  1036. Heart Disease & Stroke Prevention and Diabetes Prevention & Control Program
  1037. Heart Failure Clinical Trials Network
  1038. Hepatitis C Prevention in Society Because of Treatment in United States Prisons
  1039. HERCULES: Health and Exposome Research Center at Emory 5 Yr - Competitive Renewal
  1040. Herpes Simplex Virus Type 1 and Type 2 Antibody Testing for NHANES 2012-2017
  1041. High Impact Comprehensive HIV Prevention Program
  1042. High Intensity Interval Training in Heart Failure: The Gold Standard of Future Patient Care
  1043. Highlighting Rheumatic Disease through Decision-Based Learning
  1044. HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progress
  1045. HIV and Aging: From the Mitochondria to the Metropolis
  1046. HIV Care Equity & Access through Linkage (HEAL) Atlanta Innovation Project
  1047. HIV Early Intervention Services Program
  1048. HIV Early Intervention Services Program
  1049. HIV/HCV Switch Registry
  1050. HIV Vaccine and Biomedical Prevention Research Project - Rwanda
  1051. HOG Comprehensive Care and Research Support Grant FY 17/18
  1052. Home-based telehealth stroke care
  1053. Home or Away From Home Study
  1054. Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities
  1055. Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities
  1056. Host Factors, Tumor Microenvironment and Survival in a Multiethnic Study of Hodgkin
  1057. Household Air Pollution and Health: a Multi-country LPG Intervention Trial
  1058. HPP Registry: ALX-HPP-501 - An Observational, Longitudinal, Prospective, Long-Term
  1059. HPTN 078: Enhancing Recruitment, Linkage to Care & Treatment for HIV-Infected MSM
  1060. HRSA Primary Care Training and Enhancement Awards
  1061. HRSA Primary Care Training and Enhancement Awards
  1062. Hubert H. Humphrey Fellows Program 2016-2017
  1063. Human and System Factors Contributing to Pediatric Medication Error and Injury
  1064. Huntington's Disease Society of America Education Grant
  1065. HVTN Protocol Funding
  1066. Hybrid Coronary Revascularization Versus Coronary Artery Bypass Surgery For Treatment
  1067. I4T-MC-JVCU: Phase 3 Study of Capecitabine & Cisplatin (RAINFALL)
  1068. IAVI Zambia 2014: Federal
  1069. iChoose Kidney Decision Aid for Treatment Options
  1070. Identification of Genetic and Metabolomic Markers Influencing Dystonia
  1071. Identifying Epigenetic Mechanisms Underlying Age-Related Disease Risk in CHARGE
  1072. Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
  1073. Imaging Policy Studies, Outreach and Mentorship Program
  1074. Imaging Policy Studies, Outreach and Mentorship Program
  1075. The Impact of Prognosis on the Treatment of Patients with Localized Tumors
  1076. Impact Evaluation of Community Health Clubs in Rwanda (CBEHPP)
  1077. Impact of a Smartphone App Reminder on Adherence to Aspirin Prescribed
  1078. Impact of a Technology-based eIntervention on Cardiovascular Health among Blacks
  1079. Impact of a Technology-based eIntervention on Cardiovascular Health among Blacks
  1080. Impact of drug use on HIV/STI risk across development among African American females
  1081. Impact of Drug Use Treatment on HIV Risk Behaviors: An Integrative Data Analysis
  1082. Impact of Eliminating Nonmedical Exemptions in California
  1083. Impact of Jewish Genetic Disease Education and Outreach on College Campuses
  1084. Impact of Prenatal Insecticide Exposure on Neurodevelopmental Trajectories in a Thai Birth Cohort
  1085. Impact of Progestin Contraception on Risk of HIV Acquisition
  1086. Impact of Trauma Exposure on Critical Periods in Brain Development
  1087. Impacts of Human Movement on Regional Strain (Progress Report 3)
  1088. Implementation Research Initiative to Accelerate Scale-up Kangaroo Care
  1089. Implementing a Continuous Healthcare Innovation and Entrepreneurship Framework
  1090. IMProved Atlanta Correctional Testing (IMPACT)
  1091. Improved Biomarkers and Clinical Outcome Measures RFA: A Study of Eye Tremor
  1092. Improved Risk-Stratification and Personalized Therapy in Mantle Cell Lymphoma
  1093. Improving Birth Outcomes
  1094. Improving Linkages Between CHCs and CMHCs
  1095. Improving Access Through a Novel Smartphone Application
  1096. Improving Allocation of Limited HIV Prevention and Treatment Resources in Zambia
  1097. Improving Allocation of Limited HIV Prevention and Treatment Resources in Zambia
  1098. Improving communication about physical functioning between dialysis patients
  1099. Improving Concussion Reporting Behaviors Across All NCAA Member Institutions
  1100. Improving Health Literacy in African American Prostate Cancer Patients
  1101. Improving Health Literacy in African American Prostate Cancer Patients
  1102. Improving MISR'S Capability of Predicting Ground Level PM2.5 Concentrations with Observed Aerosol Vertical Profiles
  1103. Improving Palliative Care Through an Intergrated Oncology Model
  1104. Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons
  1105. Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons
  1106. Improving Post-partum Intrauterine Device Services
  1107. Improving PrEP Access for Gay and Bisexual MSM in the US
  1108. Improving Screening Tools to Better Predict High-Grade Anal Dysplasia for Women
  1109. Incorporating SBIRT Training into APRN Program Curriculum
  1110. Increasing Reach and Implementation of Evidence Based Programs for Cancer Control
  1111. Innovative Civic Engagement as a Tool for HIV Prevention in Port Elizabeth, South Africa
  1112. Insure Georgia Year 2
  1113. Integrated Care for Co-morbid Depression and Diabetes in India
  1114. Integrated Care for Co-morbid Depression and Diabetes in India
  1115. Integrating PrEP Screening and Referral into Family Planning Clinics in the South
  1116. Intensive Care Unit Provider Sentiment and Diagnostic Imaging Utilization
  1117. Intergenerational Impact of Genetic and Psychological Factors on Blood Pressure
  1118. CMX001-351-EA: Intermediate-size, Expanded Access Protocol: Brincidofovir
  1119. Interprofessional Student Hotspotting at Grady Hospital
  1120. Intervention and Outcomes in Duarte Galactosemia
  1121. INTREPID: Implantable Neurostimulator for the Treatment of Parkinson's
  1122. Investigating the Impact of Georgia Medicaid Policy on Access, Resource Utilization
  1123. Investigating the Lifelong Cost Benefit of Allogeneic Stem Cell Transplantation for Children with Sickle Cell Disease
  1124. Iontophoretic Dexamethasone Phospate Compared to Prednisolone Acetate
  1125. IRB Insecticides for Malaria Control and Child Neurodevelopment in South Africa
  1126. ISCHEMIA Trial - Ischemia Coordinating Center
  1127. IUD, implant, and condoms: sexual and perinatal HIV prevention in Rwandan couples
  1128. JAZZ -15-007; A phase 3, randomized, adaptive study comparing the efficacy and safety
  1129. JJ Trials- KIDS: Knowing about Intervention implementation in Detention Sites
  1130. JJ Trials- KIDS: Knowing about Intervention Implementation in Detention Sites
  1131. JScreen Education and Screening Initiative: Impacting the Health of the Jewish Community
  1132. JScreen: Marcus Foundation Support
  1133. JScreen Promotional Screenings
  1134. JScreen Promotional Screenings- Colorado Area
  1135. K23-Study of Ziovudine
  1136. Keep It Up
  1137. Kenya Health Workforce
  1138. Using Kiosks to Screen for Intimate Partner Violence
  1139. KYOWA 6002 - A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized
  1140. Language Exposure in the NICU as a Modifiable Determinant of Neurodevelopmental Outcomes
  1141. Large-scale Medical Informatics for Patient Care Coordination and Engagement
  1142. Latin-American Center of Health Education for People with Lupus and their Caregivers
  1143. LCI699 A Phase III, multi-center, double-blind, randomized withdrawal study of LCI
  1144. Leadership and Operations Center (LOC); AIDS Clinical Trial Research Group (ACTG)
  1145. LEOPARD Study: Multicenter, Observational, Post-Market, Real-World Study
  1146. Leveraging community and peer-based approaches to impact the HIV treatment cascade
  1147. Leveraging Community and Peer-based Approaches to Impact the HIV Treatment Cascade
  1148. Limited vs Comprehensive Standardized Musculoskeletal Ultrasound Examination
  1149. Linking Spatial Access and Health Outcomes for Pediatric Asthma
  1150. LitCog III: Health Literacy and Cognitive Function among Older Adults
  1151. Lives Across Time
  1152. LJ501-CRG01: A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center
  1153. Longitudinal Evaluation of Amyloid Risk and Neurodegeneration- AA Site
  1154. Longitudinal Phenomics and Genetics of Severe Asthma
  1155. Long Term Effects of Preadolescent Nutritional Status on Heart Growth and Function
  1156. Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)
  1157. Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)
  1158. Lower-Income Families Pay A Higher Share Of Income Toward National Health Care Spending Than Higher-Income Families Do
  1159. LS1293: Effect of Vitamin D Replacement on Tumor Response and Survival Parameters
  1160. LSC Training-Merced County, CA Dept of Public Health
  1161. LTS14116: an open-label, muticenter, multinational extension study
  1162. Lung endothelial barrier function and its deregulation
  1163. M11-089 Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib
  1164. M12-914: A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Pacli
  1165. M360-L102: A Phase 3, Multi-Center, Open-Label Study of a Levonorgestrel-Releasing
  1166. MAC AIDS Foundation
  1167. Making it Last: A Randomized, Controlled Trial of a Home Care System to Promote
  1168. MAMANIEVA: Engaging grandmothers to improve maternal and child nutrition
  1169. Managing Epilepsy Well: Adapting Project UPLIFT for Hispanic Adults with Epilepsy
  1170. Managing Epilepsy Well: Adapting Project UPLIFT for Hispanic Adults with Epilepsy
  1171. Maternal and Newborn Health In Ethiopia Partnership (MaNHEP)
  1172. Market Research to Predict Emerging Tobacco Product Use in Diverse Young Adults
  1173. Maryland Lifestyle Coach Trainings
  1174. Maternal and Child Survival Program-JHPIEGO
  1175. Maternal Mortality Review Data System
  1176. Maternal nutrition and lactation in India
  1177. Maternal Stress and the Gut-Brain Axis in African American Infants
  1178. Maternal Stress and the Gut-Brain Axis in African American Infants
  1179. Maternal Substance Abuse and Child Development Project
  1180. Maternity in developing countries
  1181. Mathematical Models to Inform Effective Home-use HIV Testing Strategies for MSM
  1182. Maturing Out: Childhood and Adolescent Predictors of Transitions in Alcohol Use in Young
  1183. MDV3100-13- Phase 3 Study of Enzalutamide Plus Leuprolide
  1184. Measuring and improving maternal and child health outcomes through tablet-based data collection and educational outreach among refugee women in Clarkston, Georgia
  1185. Measuring and Improving Maternal and Child Health Outcomes Through Tablet-Based Data Collection and Educational Outreach Among Refugee Women in Clarkston, Georgia
  1186. Measuring the impact of evidence on blood transfusion rates
  1187. Mechanisms and Longitudinal Effects of Stigma on Women's Adherence and Outcomes
  1188. Mechanisms of Intergenerational Impact of Maternal Trauma
  1189. Mechanisms of Intergenerational Impact of Maternal Trauma
  1190. Mechanisms of Risk and Resilience in ASD: Ontogeny, Phylogeny and Gene Disruption
  1191. Medicaid Drug Therapy Management Program for Behavioral Health
  1192. Medicaid Drug Therapy Management Program for Behavioral Health
  1193. Medicaid Expansion and Reproductive Health Care for Women
  1194. Medicaid Expansion and Reproductive Health Care for Women
  1195. MEDICAL EDUCATION PARTNERSHIP INITIATIVE (MEPI) for ETHIOPIA
  1196. MEDICAL EDUCATION PARTNERSHIP INITIATIVE (MEPI) for ETHIOPIA
  1197. Medical Food Assistance Program
  1198. Medical Food Assistance Program
  1199. MEK116513: A Phase III, Randomised, Open-label Study Comparing the Combination
  1200. Mental Health
  1201. Mental Stress and Myocardial Ischemia after MI: Sex Difference and Mechanisms
  1202. Mentored Patient Oriented Research in Lymphoma
  1203. Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health
  1204. Merck V210-063-0001: A Phase III Double Blind, Randomized, Multicenter, Controlled
  1205. META-Health
  1206. Metabolomics, Oxidative Stress, and Vascular Function in Heart Failure Patients
  1207. Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression
  1208. Method Development for Survival Dynamic Regression in Chronic Disease Research
  1209. Method Development of Agreement Measures and Applications in Mental Health
  1210. Metropolitan Trajectories of HIV Epidemics and Responses in US Key Populations
  1211. Metropolitan Trajectories of HIV Epidemics and Responses in US Key Populations
  1212. Mexican-American Participatory Assessment Project: Piloting Health Promotion
  1213. mHealth Communication Tool - Reproductive Behaviors
  1214. MICRA PSR - Product Surveillance Registry (PSR) Platform Based Protocol
  1215. MicroRNA, Environmental Exposures and Newborn Outcomes
  1216. MK-3475-010-0048 - A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900)
  1217. MK-3475-054: A randomized, double- blind Phase 3 trial of the EORTC Melanoma Group
  1218. MK3475-061: Phase III Trial of MK-3475 vs Paclitaxel
  1219. MK-3475-183:Phase III Study of Pomalidomide and Low Dose Dexamethasone
  1220. MK-3475-355:Phase III Study of MK-3475, Chemo and Placebo for Breast Cancer
  1221. MK-8228 vs. Placebo in Prevention of Cytomegalovirus (CMV) Infection in HSCT
  1222. MK 8931-019-00 A phase III, randomized, placebo-controlled, parallel-group, double
  1223. MMRF-11-001: A Prospective, Longitudinal, Observational Study in Newly Diagnosed
  1224. MMY3004: Phase 3 Study Comparing Daratumumab, Bortezomib and Dexamethasone (DVd)
  1225. MMY3008: Phase 3 Study Comparing Daratumumab, Lenalidomide, and Dexamethasone (DRd)
  1226. Mobile DOT: Patient Centered Comprehensive Medication Adherence Management System
  1227. Mobile Health Intervention to Improve Perinatal Continuum of Care in Guatemala
  1228. Mobile Messaging Intervention to Present New HIV Prevention Options for MSM
  1229. Mobile Messaging Intervention to Present New HIV Prevention Options for MSM
  1230. Mobilizing Community Systems to Engage Families in Early ASD Detection & Services
  1231. Molecular Mechanisms of Vascular Disease
  1232. Monitoring and Evaluation of Micronutrient Malnutrition
  1233. Mortality and Renal-Disease Among Lead-Exposed Workers
  1234. Mortality and Renal-disease Among Lead-exposed Workers
  1235. mPowering Maternal Health In Ghana (MHIG)
  1236. MPP - MultiPoint Pacing Post Market Study
  1237. MPS VI CLINICAL SURVEILLANCE PROGRAM
  1238. MPS VI Clinical Surveillance Program
  1239. MSB-DR003: Prospective, Multicenter, Randomized, Double-blind, Placebo
  1240. Multidisciplinary Research Training to Reduce Inequities in Cardiovascular Health
  1241. Multidisciplinary Research Training to Reduce Inequities in Cardiovascular Health
  1242. Multilevel Predictors of FollowUp After Anal Cancer Screening in HIV-Infected Individuals
  1243. NAPRTCS Acthar Registry
  1244. National Alzheimer's Coordinating Center (NACC)
  1245. National Alzheimer's Coordinating Center (NACC)
  1246. National Ebola Training and Education Center
  1247. National Longitudinal Outcomes Following Surgical Therapy of Lung Cancer
  1248. Natural History Study of Type 1 Diabetes
  1249. Naturally Acquired Immunity to Norovirus in a Newborn Cohort in Peru
  1250. Naturally Acquired Immunity to Norovirus in a Newborn Cohort in Peru
  1251. NBI-98854 for the Treatment of Tardive Dyskinesia - Phase 3
  1252. NCTN Nursing Research Traineeship
  1253. Nebraska Department of Health & Human Services, Division of Public Health
  1254. Nebraska-Tobacco Strategic
  1255. Neighborhood Factors, Sexual Risk, and STIs in HIV-Infected and High-Risk Women
  1256. NEOD001-CL002: Phase 3 Study of NEOD001 Plus SOC-vs-Placebo Plus SOC
  1257. Neonatal Anemia and Thrombocytopenia: Pathophysiology and Treatment
  1258. Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE)
  1259. Nephrotic Syndrome Rare Disease Clinical Research Network (NEPTUNE)
  1260. NEUROLOGICAL EMERGENCIES TREATMENT TRIALS (NETT) NETWORK CLINICAL SITE HUBS
  1261. New and Integrated Perspectives on Modification of Tamoxifen Effectiveness
  1262. New Approaches for Empowering Studies of Asthma in Populations of African Descent
  1263. Newborn Screening Pilot Study for Adrenoleukodystrophy (ALD)
  1264. Newborn Screening Program in India (PerkinElmer)
  1265. New Enrollment Post-Approval Study of the Argus® II
  1266. New Hampshire Lifestyle Coach Training
  1267. New Lysosomal Storage Disease Healthcare Advocate Workshop
  1268. Next generation prognostic models for patients with lymphoma
  1269. NHBS Transgender Survey Development
  1270. NI-0501-05: Multicenter Study for the Long-term Follow-up of HLH Patients who
  1271. NICHD Neonatal Research Network Capitation Funding
  1272. NINDS Stroke Trials Network
  1273. Non-Hodgkin's Lymphomas
  1274. Nonalcoholic Steatohepatitis Clinical Research Network
  1275. North Clayton High School-Based Health Center
  1276. Novel methods for research on young rural opioid users at risk of HIV, HCV & OD
  1277. Novel Text-Message Interventions to Improve Surgical Outcomes
  1278. NovoNordisk Answer Registry
  1279. NRG Oncology NCORP Research Base
  1280. Obizur_241302: POST-MARKETING Non-interventional Safety Evaluation of Obizur in the Treatment of Bleeding Episodes for Patients With Acquired Hemophilia A
  1281. Ocular Fundus Abnormalities for Acute Risk Stratification in TIA and Minor Stroke
  1282. Ocular Hypertension Treatment Study 20-Year Follow-up: Clinical Center Grant
  1283. Oklahoma Tobacco Settlement Endowment Trust (TSET) PHAO
  1284. Online Social Networking Use Among Individuals Affected with Lysosomal Storage Disease
  1285. On the Frontlines of Communities in the U.S. (FOCUS)
  1286. Open trial investigation of the CHANGE (Changing Health in Autism through Nutrition Getting Fit and Expanding Variety) Obesity Program
  1287. Operation of the Statewide Georgia Comprehensive Cancer Registry
  1288. Operation of the Statewide Georgia Comprehensive Cancer Registry
  1289. Operative Strategies to Reduce Cerebral Embolic Events After Coronary Artery Bypass Surgery
  1290. OPH1004B: a Phase 3 Randomized, Double-masked, Controlled Trial to Establish
  1291. Optimer-80-302 - A Phase 3b Multi-Center, Double-Blind, Randomized, Placebo Controlled
  1292. Optimization of the Algorithms for Screening for Critical Congenital Heart Disease
  1293. Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
  1294. Optimizing HIV Counseling Testing and Referral Through an Adaptive Drug Use Intervention
  1295. Optimizing Patients Selection for Endovascular Treatment in Acute Ischemic Stroke
  1296. OPTIMYST/SN-SIAL-351: A Phase 3, Long-Term, Open-Label and Single-Arm Study of MYO
  1297. ORal Bacterial EXtracts (ORBEX): Primary Prevention of Asthma and Wheezing in Children
  1298. OSH Surveillance & Evaluation Network
  1299. Osteonecrosis of the Jaw (ONJ) Case Registry
  1300. Otsuka 156-11-294:A Phase 3b, Multicenter, Extension Follow-up Trial to Evaluate
  1301. Outcomes of Children with Juvenile Idiopathic Arthritis-Associated Uveitis
  1302. Outpatient Clinical Treatment Services for Hansen's Disease
  1303. P03-03 PAS: Post-Approval Study: PRESTIGE® LP Cervical Disc
  1304. P11-282: AbbVie - Registry
  1305. P-30 Core Grant for Vision Research
  1306. PALLAS PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of
  1307. Pathology Imaging for Lymphoma Epidemiology of Outcomes Cohort
  1308. Patient-Centered Care: What Factors Drive Outcomes in the Hospital Setting?
  1309. Patient-Centered Approaches to Research Enrollment Decisions in Acute Cardiovascular Disease
  1310. Patient Oriented Transplant Center Metrics
  1311. PCI-32765CLL3001: Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ib
  1312. PCYC-1127-CA A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ibru
  1313. PCYC1140-IM: Phase 3 study of Ibrutinib vs Placebe in cGVHD subjects
  1314. PEACE Multicenter Studies to Improve Diagnosis and Treatment of Pediatric Candidiasis
  1315. Pediatric Environmental Health Specialty Unit (PEHSU) Program
  1316. Pediatric Environmental Health Specialty Unit (PEHSU) Program
  1317. Pediatric Heart Failure: Patient Interviews; Evaluation of Clinical Outcome Assessment
  1318. Pediatric Heart Network Emory University
  1319. Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
  1320. Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)
  1321. Phase 3 Tanezumab for adults with chronic low back pain
  1322. Phase 3 Triamcinolone Acetonide Injectible Suspension (CLS-TA) for Macular Edema
  1323. Phase IV Post Marketing Study Following INTERCEPT Transfusion
  1324. Phenotyping of Heart Failure With Preserved Ejection Fraction Via Tensor Factorization
  1325. Photodynamic Therapy (PDT) Oncology Registry
  1326. PHP-OCM-301:Phase 3 Study of Melphan/HDS Trmt. Hepatic-Dominant Ocular Melanoma
  1327. Physical Activity, Fatigue and Oxidative Stress in Pediatric Oncology Patients
  1328. Pilot Study of a Mindful Eating Smartphone Application for College Women with Subclinical
  1329. Pilot Test of Reading in School-Aged Children Treated for Unilateral Congenital
  1330. PKUDOS-PKU Demographics, Outcomes and Safety Registry
  1331. Place Characteristics and disparities in HIV in IDUs: A multi-level analysis NHBS
  1332. Place Characteristics and Disparities in HIV in IDUs: A Multi-level Analysis NHBS
  1333. Planning for Regional Centers of Research Excellence in Non-communicable Diseases
  1334. PLATINUM Diversity
  1335. Policy, Advertising and Social Media Related to E-cigarette Consumer Behavior
  1336. Population Based Study of Breast Cancer Decision Support Networks
  1337. Population Dynamics and Evolution of Antibiotic Treatment and Resistance
  1338. Positively Transforming Emory's Diverse Culture
  1339. Post Traumatic Stress Disorder and Cardiovascular Disease Risk
  1340. Preclinical Alzheimer's Disease Biomarkers: Effects of Midlife Vascular Factors
  1341. Preclinical Support for Optimizing Pembrolizumab and Dose Escalation/Fraction De-escalation SRS
  1342. Predicting Response to Standard Colitis Therapy: The PROTECT Study
  1343. Pregnancy Folate Status & Early Childhood Respiratory & Atopic Disease Outcomes
  1344. Pregnancy Folate Status & Early Childhood Respiratory & Atopic Disease Outcomes
  1345. A Preliminary Test of iHealthHome for Improving Outcomes in Persons with Heart Failure and Diabetes
  1346. Prenatal, Intrapartum and Infant Antibiotic Use and Atopic Diseases in Childhood
  1347. Prenatal Exposure to Traffic Emissions and Incident Asthma in a Birth Cohort
  1348. Prenatal folic acid and risk for autism spectrum disorders
  1349. Presurgical Applications of fMRI in Epilepsy
  1350. Preventing Future Myocardial Infarction and Death
  1351. Prevention of PTSD in the Emergency Department
  1352. Prevention of vascular calcification in chronic kidney disease
  1353. Prevention of Vascular Calcification in Chronic Kidney Disease
  1354. Primary prevention of intimate partner violence in India
  1355. Primary Prevention of Intimate Partner Violence in India
  1356. Progress Report: A Mobile Personal Health Record for Behavioral Health Homes
  1357. Progress Report: A Mobile Personal Health Record for Behavioral Health Homes
  1358. Progress Report: Understanding Child Mental Health Services in the Public Safety
  1359. Project Name
  1360. Project ACTS II: Increasing Donor Registration among African Americans
  1361. Project Healthy Grandparents
  1362. Project Healthy Grandparents
  1363. Project MinE US-Whole Genome Sequencing of a Large Cohort of Sporadic ALS Patients
  1364. Project UPLIFT to Reduce Anxiety and Depression in CF Patients
  1365. Proleukin® Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
  1366. Prolonged Exposure Therapy in the Primary Care Setting
  1367. Promoting the Safe Use of Pediatric Liquid Medications
  1368. Proof of Paradigm in Cost-Effectiveness Analysis with Novel Therapeutics
  1369. Proof of Paradigm in Cost-Effectiveness Analysis with Novel Therapeutics
  1370. Prospective Determination of the Epigenetic Response to Trauma
  1371. Prospective, Longitudinal, Multinational Registry of Patients with Newly Diagnosed Peripheral T-Cell Lymphoma
  1372. Prospective Registry Study in a Global HD Cohort- Enroll HD
  1373. Protocol 156-13-211 A Phase 3b, Multi-center, Open-label Trial to Evaluate the
  1374. Provider-led Plans and Insurance Affordability
  1375. Providing online counseling for home based HIV testing
  1376. Psychiatry, PTSD and Anxiety
  1377. Effects of Early Psychological Intervention to Prevent PTSD
  1378. Psychosis
  1379. Psychosocial Stress and Lupus among African American Women
  1380. Psychosocial Stress and Lupus among African American Women
  1381. PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
  1382. PTSD and Ischemic Heart Disease Progression: A Longitudinal Twin Study
  1383. Public health aspects of diabetes and chronic diseases
  1384. Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
  1385. Qualitative Data Analysis for Planned Parenthood, New York
  1386. Quality, Economic Outcomes, and Sustainability of Telepsychiatry (QUEST)
  1387. Quality, Economic Outcomes, and Sustainability of Telepsychiatry (QUEST)
  1388. Quality of Epilepsy Treatment and Costs in Older Americans by Race (QUIET CARE)
  1389. Quantifying Heterogeneities in Dengue Virus Transmission Dynamics
  1390. R2222-RSV-1332: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
  1391. RaDIANT Community Study to Reduce Disparities in Access to Kidney Transplantation
  1392. RaDIANT Community Study to Reduce Disparities in Access to Kidney Transplantation
  1393. rAd-IFN-CS-003: A Phase III, Open Label Study to Evaluate the Safety and Efficacy
  1394. Rapid Development and Deployment of Non-Physician Providers in Critical Care
  1395. Rapid Indoor Residual Spraying to Control Aedes Aegypti Mosquitoes
  1396. RCN-UBE:The Neuroscience Case Network (NeuroCaseNet)
  1397. Readmission Due to Pulmonary Edema in Hemodialysis Patients
  1398. Reducing Disparities among Kidney Transplant Recipients
  1399. Reducing Disparities in Living Donation among African Americans
  1400. Reducing HIV vulnerability through a multilevel life skills intervention for adolescents
  1401. Reducing HIV Vulnerability Through a Multilevel Life Skills Intervention for Adolescents
  1402. Reducing Skin Cancer Risk in Childhood Cancer Survivors
  1403. REGENERATE 747-303: A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Control
  1404. Regional Genetic and Newborn Screening Services in Region 3
  1405. Region IV Public Health Training Center (R-IV PHTC)
  1406. Region IV Public Health Training Center (R-IV PHTC)
  1407. Registries Research Support Agreement
  1408. ReliefLink: A Preventative Mobile Toolkit for Follow-Up Behavioral Health Care
  1409. Repredix: Multi-Modal Monitoring for the Prediction of Heart Failure Decompensation
  1410. Reproductive and Environmental Health Network
  1411. Reproductive and Environmental Health Network
  1412. Research Agreement: Comparison Study of Two Methodologies to Prepare Platelet
  1413. Residential Care Transition Module
  1414. Resistance testing versus adherence support for management of patients with virologic failure on first-line antiretroviral therapy in sub-Saharan Africa: An open-label randomized controlled trial
  1415. Resolute INTEGRITY US: A Postapproval Study of the Medtronic Resolute Integrity Z
  1416. Revisiting R.A.C.E.: Leveraging Archival Resources for the Purpose of Reducing AIDS
  1417. Risk and Resilience to Cardiovascular Disease in Southeastern Blacks
  1418. Risk Factors for AIDS Among Drug Users: Getting close to zero.
  1419. Risk Factors for AIDS Among Drug Users: Getting close to zero
  1420. Risk Profiles for Suicidal Behavior in the General Population
  1421. Risk Profiles for Suicidal Behavior in the General Population
  1422. ROADSTER 2 Registry
  1423. Rockdale Reentry Program Grant
  1424. Role of Prevalence and Chronic Disease Treatment in Decline in Healthcare Spending
  1425. Romantic Partner Effects on Inflammation among African Americans.¿
  1426. Routinization of HIV Testing within the Grady Health System
  1427. Routinization of HIV Testing within the Grady Health System (FC)
  1428. Ryan White Comprehensive AIDS Resources
  1429. SAFE-DCB U.S. Registry, Protocol #BPV-14-006
  1430. Safety, Pharmacokinetics, and Resistance to Bedaquiline in XDR TB and HIV
  1431. Safe Water: Access to Clean Water in Health Facilities and Communities
  1432. SaniPath-Typhoid and Environmental Surveillance Strategy
  1433. Sanitation, Water, and Instruction in Face-Washing for Trachoma
  1434. Sanitation, Water, and Instruction in Face-Washing for Trachoma
  1435. SC2I-Surgical Critical Care Initiative
  1436. School-Based Health Center Promotora Program
  1437. SCORE2: Study of Comparative Treatments
  1438. Screening for prediabetes
  1439. Seattle Children's Research Institute OPTIMIZE
  1440. SEER Program
  1441. (SEER POC 2016-01) - Patterns of Care / Quality of Care Study: Diagnosis Year 2015
  1442. Serious Communicable Disease Unit Care Team and the Ebola Virus Disease Challenge
  1443. Serious Hazards of Transfusion & Cellular Therapies: Mechanisms and Intervention
  1444. Severe Asthma Research Program (SARP III Protocol)
  1445. SHARE: Statistical Health Information Release with Differential Privacy
  1446. S-ICD Post Approval Study
  1447. Sickle Cell Disease
  1448. SILVER-AMI
  1449. Single Ventricle Reconstruction Trial III: Brain Connectome and Neurodevelopmental
  1450. Skin Vaccination Against Influenza in the Young And Aged
  1451. Sleep Apnea Health Disparities in Mexican-American Stroke Patients
  1452. Sleep Apnea Health Disparities in Mexican-American Stroke Patients
  1453. Sleep Disturbance as a Mechanism for Ischemic Heart Disease in PTSD
  1454. Smartphone Enabled Home Based Cardiac Rehabilitation
  1455. Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized Trial
  1456. SNAP-Ed Evaluation - Emory - Child Care (Contract with HealthMPowers)
  1457. SNAP-Ed Evaluation for Child Care and Nutrition PSE Survey - healthMpowers contract
  1458. Social and Adaptive Learning through Visual Expression for Adults with Autism
  1459. Social Capital and Engagement in Care Among Young Black MSM Living with HIV
  1460. Social Capital and Engagement in Care Among Young Black MSM Living with HIV
  1461. Social Determinants of Inflammation and Metabolic Syndrome among African Americans
  1462. Social Determinants of Inflammation and Metabolic Syndrome among African Americans
  1463. Social Determinants of Male-male Sexual Violence Victimization and Perpetration
  1464. Social Isolation and Retention in Care among Older Adults Living with HIV/AIDS
  1465. Social Isolation and Retention in Care among Older Adults Living with HIV/AIDS
  1466. Social Stress, Inflammation, and Chronic Kidney Among African Americans
  1467. Social Stressors and Atherosclerosis in African-American Women with Lupus
  1468. Software and Methods for Integrative Cancer Microscopy Imaging
  1469. SOM230G2304: A randomized, double-blind phase III study pasireotide LAR
  1470. South Carolina Lifestyle Coach Training 2015
  1471. South Carolina Lifestyle Coach Training 2015
  1472. South Dakota 2016 Spring Tobacco Control Institute
  1473. South Dakota Community Tobacco Control Toolkit
  1474. South Dakota Implementation Diabetes and Heart Disease Coaching
  1475. Southeast Regional Genetics Network
  1476. Southwest Telehealth Resource Center (SWTRC)
  1477. SSB 11-02: Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
  1478. Statistical Support for Syndromic Surveillance
  1479. Step It Up: Diabetic Population Management
  1480. STI and Implications for HIV Transmission and Prevention
  1481. STI Clinical Trials Group Consortium
  1482. St. Jude Medical Product Longevity and Performance Registry
  1483. Strengthening the System of Care for Older Adults with Mental Illness in Georgia
  1484. Stress and Unintended Pregnancy in Adolescence and Young Adulthood
  1485. Stress and Unintended Pregnancy in Adolescence and Young Adulthood
  1486. Stress Related Psychobiology and Inflammation in African- American Women Progress
  1487. Study of Surgical Decisions and Biomarkers in Severe Traumatic Brain Injury
  1488. Surveillance, Epidemiology and End Results (SEER)
  1489. Surveillance, Epidemiology and End Results (SEER)
  1490. Surveillance of Congenital Heart Defects Across the Lifespan
  1491. Surveillance of Congenital Heart Defects Across the Lifespan
  1492. Sustainability, Distribution and Cost-effectiveness of Self-Management for persons
  1493. SWASH+ 2: Sustaining School WASH Governance
  1494. Swash+: Evaluation of Sustainability, Cost, and Use of Private Sector Service
  1495. Symptom Care at Home: Deconstructing the Intervention
  1496. Systems of care, nursing processes, and quality outcomes
  1497. Systems Genetics of Alcoholism: Network-based Approaches for Genetics Association
  1498. Tagging Medical Data Streams with patient Photographs to Decrease Patient Misidentification Errors
  1499. Tailoring a HIV Prevention Intervention for College-aged Black Women
  1500. Tali Registry
  1501. Talk With Me Baby
  1502. Targeted Payment Cuts to Reduce Unproven Care
  1503. TARGET-NASH: A 5-year Longitudinal Observational Study of Patients with Nonalcohol
  1504. Task-Specific Compression for Biomedical Big Data
  1505. TBI Endpoints Development (TED)
  1506. Technical Assistance and Research for Indian Nutrition and Agriculture (TARINA)
  1507. Technical Support to Bihar: Improving Health, Nutrition Coverage and Outcomes
  1508. Telehealth Resource Center Grant Program
  1509. Telerehabilitation in the Home vs Therapy In-clinic for Patients with Stroke
  1510. Telerehabilitation in the Home vs Therapy In-clinic for Patients with Stroke
  1511. Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimer's Care
  1512. Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimer's Care
  1513. The Association of State and Territorial Dental Directors
  1514. The Association of State and Territorial Dental Directors
  1515. The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center
  1516. The Autism MEAL Plan: A Parent Training Curriculum to Manage Eating Aversions
  1517. The Burden of Chikungunya and Dengue Transmission, Infection and Disease in Kenya
  1518. The Burden of Poor Oral Health in Georgia
  1519. The Center for Cognition and Affect in Chronic Illness
  1520. The Center for Cognition and Affect in Chronic Illness
  1521. The Center on Reproductive Health Access, Policy, & Social Determinants Innovation
  1522. The Center on Reproductive Health Access, Policy, & Social Determinants Innovation
  1523. The CFAR Social & Behavioral Sci Rsch Network Natl Scientific Meeting
  1524. The Challenge of Individualizing Treatment For Patients With Breast Cancer
  1525. The Challenge of Individualizing Treatment For Patients With Breast Cancer
  1526. The Childhood Liver Disease Research and Education Network (ChiLDREN)
  1527. The Childhood Liver Disease Research and Education Network (ChiLDREN)
  1528. The Cytogenomics of Cardiovascular Malformations Consortium Registry
  1529. The Diurnal Patterns of Fatigue on Hemodialysis: A Pilot Study
  1530. The DREAMS Team: Galvanizing research participation in the Underserved PD communities
  1531. The Drivers of Diet Change and Food Choice Among Tanzanian Pastoralists Transition
  1532. The Emory Alzheimer's Disease Research Center
  1533. The Emory Alzheimer's Disease Research Center
  1534. The Georgians Organized Against Lupus (GOAL) Cohort: Advancing Health Disparities
  1535. The Girasoles (Sunflower) Study
  1536. The Global Collaborating Center in Reproductive Health in Atlanta
  1537. The Grady Health Systems and Emory University Collaborative Primary Care Training
  1538. The gut microbiome, host genetics, and risk for inflammatory bowel disease
  1539. The Impact of Enhanced, Demand-side Sanitation and Hygiene Promotion
  1540. The Impact of the Intrauterine and Early Childhood Environments on Neurocognitive and Metabolic Development in African American Youth
  1541. The Impact of Urgent Care Centers and Retail Clinics on Healthcare Access and Emergency Department Use
  1542. The Living Well Project: Early Palliative Care and MI for Persons with AIDS
  1543. The Lymphoma Epidemiology and Outcomes (LEO) Cohort Study
  1544. The Measurement and Evaluation of Competition in Healthcare Delivery Markets
  1545. The Measurement and Evaluation of Competition in Healthcare Delivery Markets
  1546. Theoretically Based Mobile App to Increase PrEP Uptake Among MSM
  1547. The Parkinson's Progression Markers Initiative (PPMI)
  1548. The Role of Behavioral Health Conditions in Healthcare Spending Growth
  1549. The Role of FADS Genotype on Prenatal DHA Supplementation and Child Growth and Development
  1550. The Scientific Registry of Transplant Recipients
  1551. The T1D Exchange Type 1 Diabetes Network
  1552. The Value of Children's Hospitals: Are Increased Costs Justified by Improved Outcomes or Driven by Internal and External Economic Forces?
  1553. Thriving Schools Project
  1554. TN Dept of Health Lifestyle Coach Trainings and Webinars
  1555. Tobacco 101 Webinar Series for Disparities Grantees, 2016 - 2017
  1556. ToxIC IN3 Registry
  1557. TOZ-CL05 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo
  1558. Tracking Outcomes and Practices in Pediatric Pulmonary Hypertension:TOPP-2Registry
  1559. Training a new generation of vaccinologists
  1560. Training a New Generation of Vaccinologists
  1561. Training in Interventions to Improve Outcomes in Chronic Conditions
  1562. Training in Systems and Integrative Biology Neuroscience
  1563. "Trajectories of Kidney Dysfunction Among Older Adults with CKD" Project
  1564. Transforming Vaccine Hesitancy into Confidence: Research to Address Parents' Vaccine
  1565. Transition from Pediatric to Adult-Oriented Healthcare Among Youth Living with HIV
  1566. Translational Physician-Scientist Training Program in Oncology
  1567. TRC112121: Multi-Centre Study of Eltrombopag or Placebo in Combination with Azacit
  1568. Treatment Decision Making in Low-Risk Thyroid Cancer
  1569. Treatment Options for Depression in Patients Undergoing Hemodialysis
  1570. Trevo® Retriever Registry-for Stroke Patients Treated With
  1571. TWILIGHT Study: Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
  1572. Understanding Academics, Behavior, and Quality of Life in Children with Congenital
  1573. Understanding disparities in effective HIV treatment and prevention: Involvement
  1574. Understanding Disparities in Effective HIV Treatment and Prevention: Involvement+
  1575. Understanding Pneumococcal Evolution to Evade Vaccination in Developing Countries
  1576. Understanding Rectal HIV Transmission among At-risk MSM: Age, Intercourse, and Mucosal Injur
  1577. Understanding substance use and incident HIV/STI among young black MSM
  1578. Understanding substance use and incident HIV/STI among young black MSM
  1579. Understanding the Interplay of Social Context Sub Award w Rhode Island Hospital
  1580. UNICEF Laos- WASH in Schools Impact Study
  1581. United Way MOU - Healthy Beginnings System of Care Evaluation.
  1582. University of Pennsylvania Population Aging Research Center Pilot Study
  1583. Urban Health Initiative's Ear, Nose and Throat Telemedicine Screening Program
  1584. Urological and Renal Disease Engaging Adolescents in Adherence Collaborative
  1585. U.S. Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Registry
  1586. User-Centered, Web-based Portal to Support Regimen Adherence in Transplant
  1587. User-Centered, Web-based Portal to Support Regimen Adherence in Transplant
  1588. Using Earth Observations to Support Regional and National Environmental Health Surveillance
  1589. Using Longitudinal Data to Characterize the Natural History of Fragile X Syndrome
  1590. Using Mobile Health Technology to Improve the Continuum of Neonatal Care (BWH)
  1591. Using The Electronic Medical Record to Monitor and Evaluate Public Health Impact
  1592. USWM-AP2-3000: A Phase 3, Open-Label Study of the Safety, Efficacy, and Tolerability
  1593. V118-05, A Phase III, Stratified, Randomized, Observer Blind, Controlled
  1594. Vaccine & Immunization Program
  1595. Vaccine Induced Immunity in the Young and Aged
  1596. Vaccine Induced Immunity in the Young and Aged
  1597. VAMC Atlanta/Geriatric & Extended Care & Rehab Service--IPA
  1598. VCT with Primary and Concurrent Partners to Prevent HIV Transmission
  1599. Vedolizumab IV Trial, Takeda Study
  1600. Vulnerability to Drug Use and HIV: Advancing Prevention for Rural African American
  1601. Vulnerability to Drug Use and HIV: Advancing Prevention for Rural African Americans
  1602. Vulnerable communities
  1603. VX13-809-011 Part B: A Phase 3, Open-Label Study to Evaluate the Pharmacokineti
  1604. VX14-661-107: A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel
  1605. VX14-661-110: A Phase 3, Open-label, Rollover Study to Evaluate the Safety and
  1606. Warrior Injury Assessment Manikin [WIAMan]
  1607. Water, Sanitation and Hygiene (WASH) Benefits Project
  1608. Water Research Emory-Niteen (PR20836746)
  1609. Web-based organ donation education for African Americans
  1610. WO39210: Phase III, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study
  1611. Women's Economic Empowerment and IPV in Colombia
  1612. Worker Training Program (WTP) Ebola Biosafety and ID
  1613. Worker Training Program (WTP) Ebola Biosafety and ID
  1614. Worksite Lifestyle Program for Reducing Diabetes and CVD Risk in India
  1615. Worksite lifestyle program for reducing diabetes and CVD risk in India
  1616. XL PAD Registry
  1617. Young Africans' Social Representations of HIV/AIDS, 1997-2014
  1618. Young Africans' Social Representations of HIV/AIDS, 1997-2014